| Process Research Category and Antibody Product Link |
% of Publications within last year |
| peptidyl-proline modification antibodies |
100.0% |
| protein K27-linked ubiquitination antibodies |
100.0% |
| response to magnetism antibodies |
100.0% |
| cyanate catabolic process antibodies |
100.0% |
| G-protein signaling, coupled to cAMP nucleotide second messenger antibodies |
100.0% |
| serine family amino acid catabolic process antibodies |
100.0% |
| mitochondrial threonyl-tRNA aminoacylation antibodies |
100.0% |
| cellular response to magnetism antibodies |
100.0% |
| cell migration involved in kidney development antibodies |
100.0% |
| miRNA catabolic process antibodies |
100.0% |
| sensory organ boundary specification antibodies |
100.0% |
| histone H3-T3 phosphorylation antibodies |
75.0% |
| Wnt receptor signaling pathway, calcium modulating pathway antibodies |
60.0% |
| monoterpenoid metabolic process antibodies |
50.0% |
| dibenzo-p-dioxin metabolic process antibodies |
50.0% |
| protein K11-linked ubiquitination antibodies |
50.0% |
| response to stilbenoid antibodies |
50.0% |
| cellular response to transforming growth factor beta stimulus antibodies |
50.0% |
| multicellular organismal aging antibodies |
50.0% |
| response to transforming growth factor beta stimulus antibodies |
50.0% |
| G-protein signaling, coupled to cyclic nucleotide second messenger antibodies |
50.0% |
| flavone metabolic process antibodies |
50.0% |
| protein glycosylation in endoplasmic reticulum antibodies |
50.0% |
| renal vesicle progenitor cell differentiation antibodies |
50.0% |
| nucleotide-sugar metabolic process antibodies |
50.0% |
| histone mRNA metabolic process antibodies |
50.0% |
| protein glycosylation in Golgi antibodies |
50.0% |
| miRNA metabolic process antibodies |
44.8% |
| COPII vesicle coating antibodies |
42.9% |
| lysine catabolic process antibodies |
40.0% |
| plus-end-directed vesicle transport along microtubule antibodies |
40.0% |
| L-lysine catabolic process antibodies |
40.0% |
| protein linear polyubiquitination antibodies |
37.5% |
| hippo signaling cascade antibodies |
36.2% |
| dendrite self-avoidance antibodies |
34.8% |
| cellular response to organic cyclic compound antibodies |
33.3% |
| neurofilament bundle assembly antibodies |
33.3% |
| nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway antibodies |
33.3% |
| multicellular organismal homeostasis antibodies |
33.3% |
| dorsal/ventral axon guidance antibodies |
33.3% |
| histone H3-S28 phosphorylation antibodies |
33.3% |
| gamma-aminobutyric acid catabolic process antibodies |
33.3% |
| visceral serous pericardium development antibodies |
33.3% |
| equilibrioception antibodies |
33.3% |
| peptidyl-arginine methylation antibodies |
33.3% |
| dihydrobiopterin metabolic process antibodies |
33.3% |
| epidermal growth factor catabolic process antibodies |
33.3% |
| age-dependent response to reactive oxygen species antibodies |
33.3% |
| defense response to nematode antibodies |
33.3% |
| caveolin-mediated endocytosis antibodies |
32.0% |
| ferrous iron import antibodies |
30.8% |
| glucosamine catabolic process antibodies |
30.0% |
| intermediate filament bundle assembly antibodies |
28.6% |
| lipopolysaccharide-mediated signaling pathway antibodies |
28.6% |
| nucleotide-binding oligomerization domain containing 2 signaling pathway antibodies |
28.6% |
| non-canonical Wnt receptor signaling pathway antibodies |
27.3% |
| histone monoubiquitination antibodies |
26.7% |
| lysosomal lumen acidification antibodies |
26.7% |
| response to organic cyclic compound antibodies |
25.0% |
| phosphatidylinositol-mediated signaling antibodies |
25.0% |
| cell-substrate junction assembly antibodies |
25.0% |
| I-kappaB kinase/NF-kappaB cascade antibodies |
25.0% |
| barrier septum assembly antibodies |
25.0% |
| response to thyroid hormone stimulus antibodies |
25.0% |
| nipple sheath formation antibodies |
25.0% |
| methyl-branched fatty acid metabolic process antibodies |
25.0% |
| 3-UTR-mediated mRNA stabilization antibodies |
25.0% |
| dUMP metabolic process antibodies |
25.0% |
| parallel actin filament bundle assembly antibodies |
25.0% |
| anthranilate metabolic process antibodies |
25.0% |
| RNA splicing, via transesterification reactions antibodies |
25.0% |
| replication fork protection antibodies |
24.5% |
| mesenchymal to epithelial transition antibodies |
24.3% |
| epithelial to mesenchymal transition antibodies |
24.3% |
| oncogene-induced senescence antibodies |
22.9% |
| proteasome regulatory particle assembly antibodies |
22.7% |
| autophagy antibodies |
22.5% |
| histone H3-S10 phosphorylation antibodies |
22.2% |
| one-carbon metabolic process antibodies |
22.2% |
| ceramide catabolic process antibodies |
22.2% |
| interleukin-6-mediated signaling pathway antibodies |
22.2% |
| short-chain fatty acid metabolic process antibodies |
22.0% |
| stress granule assembly antibodies |
21.7% |
| mammary gland bud elongation antibodies |
21.4% |
| sphingolipid catabolic process antibodies |
21.4% |
| primary miRNA processing antibodies |
21.1% |
| response to misfolded protein antibodies |
21.1% |
| sister chromatid biorientation antibodies |
21.1% |
| histone H3-R2 methylation antibodies |
21.1% |
| endosomal lumen acidification antibodies |
21.1% |
| epithelial-mesenchymal cell signaling antibodies |
21.0% |
| protein K63-linked ubiquitination antibodies |
21.0% |
| T-helper 17 cell differentiation antibodies |
20.2% |
| pre-miRNA processing antibodies |
20.1% |
| semaphorin-plexin signaling pathway antibodies |
20.0% |
| embryonic olfactory bulb interneuron precursor migration antibodies |
20.0% |
| nucleotide-binding oligomerization domain containing signaling pathway antibodies |
20.0% |
| intestinal lipid catabolic process antibodies |
20.0% |
| nucleoside triphosphate catabolic process antibodies |
20.0% |
| diacylglycerol catabolic process antibodies |
20.0% |
| keratan sulfate metabolic process antibodies |
20.0% |
| T-helper 17 cell chemotaxis antibodies |
20.0% |
| Wnt receptor signaling pathway, planar cell polarity pathway antibodies |
20.0% |
| cysteine biosynthetic process via cystathionine antibodies |
20.0% |
| nitrobenzene metabolic process antibodies |
20.0% |
| UDP-glucose metabolic process antibodies |
20.0% |
| cellular response to misfolded protein antibodies |
19.7% |
| L-serine catabolic process antibodies |
19.5% |
| multicellular organismal development antibodies |
19.4% |
| histone H2A monoubiquitination antibodies |
19.2% |
| myelination in peripheral nervous system antibodies |
19.2% |
| cytoplasmic mRNA processing body assembly antibodies |
18.5% |
| intussusceptive angiogenesis antibodies |
18.4% |
| protein deglutathionylation antibodies |
18.3% |
| early endosome to late endosome transport antibodies |
18.2% |
| iridophore differentiation antibodies |
18.2% |
| synaptic vesicle uncoating antibodies |
18.2% |
| histone ubiquitination antibodies |
17.9% |
| isoleucine metabolic process antibodies |
17.9% |
| pattern recognition receptor signaling pathway antibodies |
17.8% |
| macroautophagy antibodies |
17.7% |
| tumor necrosis factor-mediated signaling pathway antibodies |
17.6% |
| glycolipid catabolic process antibodies |
17.6% |
| somatic stem cell maintenance antibodies |
17.6% |
| retrograde axon cargo transport antibodies |
17.4% |
| orbitofrontal cortex development antibodies |
17.4% |
| N-glycan fucosylation antibodies |
17.2% |
| T-tubule organization antibodies |
17.1% |
| peroxisome fission antibodies |
17.1% |
| canonical Wnt receptor signaling pathway antibodies |
17.0% |
| endoplasmic reticulum unfolded protein response antibodies |
17.0% |
| histone demethylation antibodies |
17.0% |
| mitochondrial fragmentation involved in apoptosis antibodies |
16.7% |
| lymphocyte chemotaxis across high endothelial venule antibodies |
16.7% |
| stress granule disassembly antibodies |
16.7% |
| proepicardium development antibodies |
16.7% |
| dermatan sulfate proteoglycan metabolic process antibodies |
16.7% |
| fructose catabolic process antibodies |
16.7% |
| leukocyte migration involved in immune response antibodies |
16.7% |
| polar body extrusion after meiotic divisions antibodies |
16.7% |
| gamma-aminobutyric acid import antibodies |
16.7% |
| glycosphingolipid catabolic process antibodies |
16.7% |
| ruffle assembly antibodies |
16.7% |
| mitochondrial respiratory chain complex II assembly antibodies |
16.7% |
| metanephric renal vesicle morphogenesis antibodies |
16.7% |
| extracellular matrix-cell signaling antibodies |
16.7% |
| dihydrolipoamide metabolic process antibodies |
16.7% |
| extrinsic apoptotic signaling pathway antibodies |
16.6% |
| protein glutathionylation antibodies |
16.6% |
| histone lysine demethylation antibodies |
16.5% |
| autophagic cell death antibodies |
16.5% |
| superior temporal gyrus development antibodies |
16.4% |
| natural killer cell degranulation antibodies |
16.3% |
| protein monoubiquitination antibodies |
16.3% |
| collagen catabolic process antibodies |
16.1% |
| astrocyte fate commitment antibodies |
16.0% |
| age-dependent telomere shortening antibodies |
16.0% |
| phosphatidylinositol catabolic process antibodies |
16.0% |
| mitochondrial protein catabolic process antibodies |
15.9% |
| CD24 biosynthetic process antibodies |
15.9% |
| protein neddylation antibodies |
15.9% |
| smoothened signaling pathway antibodies |
15.8% |
| dendritic spine morphogenesis antibodies |
15.8% |
| T-helper 1 cell lineage commitment antibodies |
15.8% |
| mitochondrial fission antibodies |
15.8% |
| TRIF-dependent toll-like receptor signaling pathway antibodies |
15.6% |
| endothelial cell fate specification antibodies |
15.5% |
| thermosensory behavior antibodies |
15.4% |
| polyamine catabolic process antibodies |
15.4% |
| M phase specific microtubule process antibodies |
15.4% |
| Hsp90 deacetylation antibodies |
15.4% |
| mesenchymal cell apoptosis antibodies |
15.4% |
| histone H2B ubiquitination antibodies |
15.3% |
| protein lipoylation antibodies |
15.2% |
| oxidative DNA demethylation antibodies |
15.2% |
| medium-chain fatty acid metabolic process antibodies |
15.0% |
| Wnt receptor signaling pathway antibodies |
14.6% |
| septin ring assembly antibodies |
14.6% |
| histone H2A ubiquitination antibodies |
14.6% |
| response to unfolded protein antibodies |
14.5% |
| germ-line stem cell maintenance antibodies |
14.4% |
| branchiomeric skeletal muscle development antibodies |
14.3% |
| cellular response to insulin stimulus antibodies |
14.3% |
| protein K48-linked ubiquitination antibodies |
14.3% |
| inositol phosphate-mediated signaling antibodies |
14.3% |
| nucleotide-excision repair, DNA duplex unwinding antibodies |
14.3% |
| aggresome assembly antibodies |
14.3% |
| contractile actin filament bundle assembly antibodies |
14.3% |
| sphinganine biosynthetic process antibodies |
14.3% |
| branched chain family amino acid biosynthetic process antibodies |
14.3% |
| glucose 1-phosphate metabolic process antibodies |
14.3% |
| immunoglobulin production in mucosal tissue antibodies |
14.3% |
| de novo cotranslational protein folding antibodies |
14.3% |
| deoxyribonucleoside catabolic process antibodies |
14.3% |
| cellular ketone body metabolic process antibodies |
14.3% |
| medium-chain fatty acid biosynthetic process antibodies |
14.3% |
| nucleotide-binding oligomerization domain containing 1 signaling pathway antibodies |
14.3% |
| Roundabout signaling pathway antibodies |
14.3% |
| Notch signaling pathway antibodies |
14.2% |
| mesenchymal cell proliferation antibodies |
14.2% |
| intrinsic apoptotic signaling pathway antibodies |
14.1% |
| histone methylation antibodies |
14.1% |
| adaptive immune response antibodies |
14.1% |
| sinoatrial node cell differentiation antibodies |
14.0% |
| toll-like receptor 4 signaling pathway antibodies |
13.9% |
| protein autoubiquitination antibodies |
13.9% |
| histone H4-K16 acetylation antibodies |
13.8% |
| melanin metabolic process antibodies |
13.8% |
| endoplasmic reticulum tubular network organization antibodies |
13.8% |
| lymphangiogenesis antibodies |
13.8% |
| myeloid cell homeostasis antibodies |
13.7% |
| toll-like receptor signaling pathway antibodies |
13.7% |
| response to endoplasmic reticulum stress antibodies |
13.7% |
| histone lysine methylation antibodies |
13.7% |
| protein polyubiquitination antibodies |
13.7% |
| telomere maintenance via telomere shortening antibodies |
13.6% |
| mRNA catabolic process antibodies |
13.6% |
| Toll signaling pathway antibodies |
13.5% |
| nucleosome disassembly antibodies |
13.5% |
| valine metabolic process antibodies |
13.5% |
| MyD88-dependent toll-like receptor signaling pathway antibodies |
13.5% |
| protein sumoylation antibodies |
13.4% |
| platelet-derived growth factor receptor-beta signaling pathway antibodies |
13.4% |
| Golgi ribbon formation antibodies |
13.4% |
| T-helper cell lineage commitment antibodies |
13.4% |
| toll-like receptor 1 signaling pathway antibodies |
13.4% |
| oligodendrocyte cell fate commitment antibodies |
13.3% |
| heparan sulfate proteoglycan metabolic process antibodies |
13.3% |
| histone H4-K5 acetylation antibodies |
13.3% |
| basement membrane disassembly antibodies |
13.3% |
| centromeric core chromatin assembly antibodies |
13.3% |
| corticospinal tract morphogenesis antibodies |
13.3% |
| histone modification antibodies |
13.2% |
| toll-like receptor 2 signaling pathway antibodies |
13.2% |
| protein ubiquitination antibodies |
13.2% |
| cellular protein catabolic process antibodies |
13.2% |
| base-excision repair, DNA ligation antibodies |
13.1% |
| toll-like receptor 7 signaling pathway antibodies |
13.1% |
| toll-like receptor 3 signaling pathway antibodies |
13.1% |
| interkinetic nuclear migration antibodies |
13.0% |
| urate metabolic process antibodies |
13.0% |
| piRNA metabolic process antibodies |
13.0% |
| stem cell maintenance antibodies |
13.0% |
| innate immune response antibodies |
13.0% |
| neural crest cell fate specification antibodies |
12.8% |
| toll-like receptor 9 signaling pathway antibodies |
12.8% |
| multivesicular body sorting pathway antibodies |
12.8% |
| membrane to membrane docking antibodies |
12.8% |
| anoikis antibodies |
12.8% |
| sprouting angiogenesis antibodies |
12.8% |
| cilium assembly antibodies |
12.7% |
| spindle assembly checkpoint antibodies |
12.6% |
| kinetochore assembly antibodies |
12.6% |
| cell morphogenesis involved in neuron differentiation antibodies |
12.5% |
| anatomical structure regression antibodies |
12.5% |
| circadian sleep/wake cycle, REM sleep antibodies |
12.5% |
| hepatoblast differentiation antibodies |
12.5% |
| glycerol ether metabolic process antibodies |
12.5% |
| low-density lipoprotein particle mediated signaling antibodies |
12.5% |
| cellular response to glucose starvation antibodies |
12.5% |
| telomere maintenance via recombination antibodies |
12.5% |
| eye pigment granule organization antibodies |
12.5% |
| paranodal junction assembly antibodies |
12.5% |
| biphenyl catabolic process antibodies |
12.5% |
| protein desumoylation antibodies |
12.5% |
| sulfur amino acid metabolic process antibodies |
12.5% |
| ribose phosphate metabolic process antibodies |
12.5% |
| myotube differentiation involved in skeletal muscle regeneration antibodies |
12.5% |
| estrogen catabolic process antibodies |
12.5% |
| alternative nuclear mRNA splicing, via spliceosome antibodies |
12.5% |
| semicircular canal fusion antibodies |
12.5% |
| posterior lateral line neuromast primordium migration antibodies |
12.5% |
| helper T cell extravasation antibodies |
12.5% |
| tubulin deacetylation antibodies |
12.5% |
| adiponectin-mediated signaling pathway antibodies |
12.5% |
| pronephric nephron tubule morphogenesis antibodies |
12.5% |
| toll-like receptor 5 signaling pathway antibodies |
12.5% |
| stem cell fate specification antibodies |
12.5% |
| neurogenesis antibodies |
12.3% |
| neuroblast proliferation antibodies |
12.3% |
| chromatin maintenance antibodies |
12.3% |
| butyrate metabolic process antibodies |
12.2% |
| vitamin K metabolic process antibodies |
12.2% |
| septin cytoskeleton organization antibodies |
12.2% |
| RNA catabolic process antibodies |
12.2% |
| leptin-mediated signaling pathway antibodies |
12.1% |
| cellular triglyceride homeostasis antibodies |
12.1% |
| gene silencing antibodies |
12.1% |
| BMP signaling pathway antibodies |
12.0% |
| protein lipidation antibodies |
12.0% |
| riboflavin metabolic process antibodies |
12.0% |
| histone deubiquitination antibodies |
12.0% |
| plasma membrane to endosome transport antibodies |
12.0% |
| telomere maintenance via telomerase antibodies |
11.9% |
| dendritic spine development antibodies |
11.9% |
| microtubule severing antibodies |
11.8% |
| anti-apoptosis antibodies |
11.8% |
| histone H3 acetylation antibodies |
11.8% |
| androgen receptor signaling pathway antibodies |
11.8% |
| protein localization to synapse antibodies |
11.8% |
| receptor localization to synapse antibodies |
11.8% |
| glycolate metabolic process antibodies |
11.8% |
| platelet-derived growth factor receptor-alpha signaling pathway antibodies |
11.8% |
| melatonin metabolic process antibodies |
11.8% |
| chronological cell aging antibodies |
11.8% |
| mesenchymal cell differentiation antibodies |
11.7% |
| neuronal stem cell maintenance antibodies |
11.7% |
| central nervous system vasculogenesis antibodies |
11.6% |
| chromatin assembly or disassembly antibodies |
11.6% |
| macropinocytosis antibodies |
11.6% |
| chromatin remodeling antibodies |
11.6% |
| DNA demethylation antibodies |
11.6% |
| protein deubiquitination antibodies |
11.6% |
| low-density lipoprotein particle remodeling antibodies |
11.5% |
| posterior head segmentation antibodies |
11.5% |
| formate metabolic process antibodies |
11.5% |
| mitochondrial respiratory chain complex assembly antibodies |
11.5% |
| virus-host interaction antibodies |
11.5% |
| extracellular matrix disassembly antibodies |
11.5% |
| embryonic pectoral fin morphogenesis antibodies |
11.5% |
| protein targeting to plasma membrane antibodies |
11.4% |
| G2/M transition DNA damage checkpoint antibodies |
11.4% |
| chromatin modification antibodies |
11.4% |
| ATP catabolic process antibodies |
11.4% |
| fumarate metabolic process antibodies |
11.4% |
| succinate metabolic process antibodies |
11.3% |
| neuromast development antibodies |
11.3% |
| protein deneddylation antibodies |
11.3% |
| ephrin receptor signaling pathway antibodies |
11.3% |
| heterochromatin assembly antibodies |
11.3% |
| oxidative stress-induced premature senescence antibodies |
11.2% |
| neuroprotection antibodies |
11.2% |
| glycerol metabolic process antibodies |
11.2% |
| progesterone receptor signaling pathway antibodies |
11.2% |
| cell fate commitment antibodies |
11.1% |
| small molecule metabolic process antibodies |
11.1% |
| exogenous drug catabolic process antibodies |
11.1% |
| protein heterotetramerization antibodies |
11.1% |
| ventral spinal cord interneuron fate determination antibodies |
11.1% |
| response to UV-C antibodies |
11.1% |
| embryonic process involved in female pregnancy antibodies |
11.1% |
| oenocyte development antibodies |
11.1% |
| very-low-density lipoprotein particle remodeling antibodies |
11.1% |
| pyridoxal 5-phosphate salvage antibodies |
11.1% |
| nucleotide-excision repair, DNA incision, 3-to lesion antibodies |
11.1% |
| serine family amino acid metabolic process antibodies |
11.1% |
| phytol metabolic process antibodies |
11.1% |
| glucose mediated signaling pathway antibodies |
11.1% |
| organic acid metabolic process antibodies |
11.0% |
| post-translational protein acetylation antibodies |
11.0% |
| RNA interference antibodies |
11.0% |
| cell-cell junction organization antibodies |
11.0% |
| MyD88-independent toll-like receptor signaling pathway antibodies |
11.0% |
| vascular endothelial growth factor receptor signaling pathway antibodies |
11.0% |
| intein-mediated protein splicing antibodies |
11.0% |
| zinc ion transmembrane transport antibodies |
11.0% |
| ribosomal small subunit biogenesis antibodies |
10.9% |
| cullin deneddylation antibodies |
10.9% |
| reactive oxygen species metabolic process antibodies |
10.9% |
| polyphosphate metabolic process antibodies |
10.9% |
| peroxisome proliferator activated receptor signaling pathway antibodies |
10.9% |
| nitric oxide storage antibodies |
10.8% |
| microglial cell activation antibodies |
10.8% |
| chromatin silencing antibodies |
10.8% |
| oxaloacetate metabolic process antibodies |
10.8% |
| catabolic process antibodies |
10.7% |
| triglyceride homeostasis antibodies |
10.7% |
| glial cell fate commitment antibodies |
10.7% |
| common myeloid progenitor cell proliferation antibodies |
10.7% |
| histone acetylation antibodies |
10.7% |
| renal vesicle morphogenesis antibodies |
10.6% |
| vascular endothelial growth factor signaling pathway antibodies |
10.6% |
| signalosome assembly antibodies |
10.6% |
| neural precursor cell proliferation antibodies |
10.5% |
| glutamine catabolic process antibodies |
10.5% |
| mesenchymal-epithelial cell signaling antibodies |
10.5% |
| protein targeting to lysosome antibodies |
10.5% |
| PML body organization antibodies |
10.5% |
| cloacal septation antibodies |
10.5% |
| axon cargo transport antibodies |
10.5% |
| pectoral fin development antibodies |
10.5% |
| nucleosome positioning antibodies |
10.5% |
| nucleosome assembly antibodies |
10.4% |
| cytosol to ER transport antibodies |
10.4% |
| cell redox homeostasis antibodies |
10.4% |
| transdifferentiation antibodies |
10.4% |
| centromere complex assembly antibodies |
10.4% |
| tendon cell differentiation antibodies |
10.4% |
| brain-derived neurotrophic factor receptor signaling pathway antibodies |
10.4% |
| neuronal action potential propagation antibodies |
10.4% |
| cellular response to cold antibodies |
10.4% |
| heme export antibodies |
10.3% |
| heme metabolic process antibodies |
10.3% |
| kinetochore organization antibodies |
10.3% |
| inflammatory cell apoptosis antibodies |
10.3% |
| protein catabolic process antibodies |
10.3% |
| synaptic vesicle clustering antibodies |
10.2% |
| flavonoid metabolic process antibodies |
10.2% |
| mesenchymal cell development antibodies |
10.2% |
| protein homooligomerization antibodies |
10.2% |
| microglia development antibodies |
10.2% |
| mitochondrial RNA surveillance antibodies |
10.1% |
| segmentation antibodies |
10.1% |
| stem cell proliferation antibodies |
10.1% |
| nitric oxide production involved in inflammatory response antibodies |
10.0% |
| copper ion import antibodies |
10.0% |
| double-strand break repair via nonhomologous end joining antibodies |
10.0% |
| nucleotide-excision repair, DNA gap filling antibodies |
10.0% |
| retrograde transport, endosome to Golgi antibodies |
10.0% |
| beta-alanine metabolic process antibodies |
10.0% |
| water-soluble vitamin metabolic process antibodies |
10.0% |
| phytoalexin metabolic process antibodies |
10.0% |
| cell surface pattern recognition receptor signaling pathway antibodies |
10.0% |
| protein folding in endoplasmic reticulum antibodies |
10.0% |
| syncytial blastoderm mitotic cell cycle antibodies |
10.0% |
| transposition, DNA-mediated antibodies |
10.0% |
| DNA catabolic process antibodies |
10.0% |
| store-operated calcium entry antibodies |
10.0% |
| succinyl-CoA metabolic process antibodies |
10.0% |
| protein localization in mitochondrion antibodies |
10.0% |
| stress-induced premature senescence antibodies |
10.0% |
| replication fork processing antibodies |
9.9% |
| cholesterol homeostasis antibodies |
9.9% |
| G-protein coupled glutamate receptor signaling pathway antibodies |
9.9% |
| epithelial cell migration antibodies |
9.9% |
| elastic fiber assembly antibodies |
9.9% |
| carnitine metabolic process antibodies |
9.9% |
| tRNA wobble uridine modification antibodies |
9.9% |
| ribonucleoprotein complex biogenesis antibodies |
9.8% |
| intraflagellar retrograde transport antibodies |
9.8% |
| T cell homeostatic proliferation antibodies |
9.8% |
| acetyl-CoA metabolic process antibodies |
9.8% |
| ribosome biogenesis antibodies |
9.8% |
| phospholipid scrambling antibodies |
9.8% |
| cell fate specification antibodies |
9.8% |
| T cell homeostasis antibodies |
9.8% |
| high-density lipoprotein particle assembly antibodies |
9.8% |
| synaptonemal complex assembly antibodies |
9.7% |
| copper ion homeostasis antibodies |
9.7% |
| white fat cell differentiation antibodies |
9.7% |
| glycosaminoglycan catabolic process antibodies |
9.7% |
| rRNA metabolic process antibodies |
9.7% |
| urothelial cell proliferation antibodies |
9.7% |
| nuclear migration antibodies |
9.7% |
| neuron remodeling antibodies |
9.6% |
| osteoblast differentiation antibodies |
9.6% |
| mitochondrial depolarization antibodies |
9.5% |
| immunological synapse formation antibodies |
9.5% |
| angiogenesis antibodies |
9.5% |
| compartment pattern specification antibodies |
9.5% |
| cilium axoneme assembly antibodies |
9.5% |
| synaptic target recognition antibodies |
9.5% |
| L-alanine metabolic process antibodies |
9.5% |
| translational attenuation antibodies |
9.5% |
| fin regeneration antibodies |
9.5% |
| myeloid dendritic cell activation antibodies |
9.5% |
| ATP-dependent chromatin remodeling antibodies |
9.4% |
| cellular glucose homeostasis antibodies |
9.4% |
| satellite cell commitment antibodies |
9.4% |
| chaperone-mediated protein transport antibodies |
9.4% |
| pore complex assembly antibodies |
9.4% |
| insulin-like growth factor receptor signaling pathway antibodies |
9.4% |
| apoptotic mitochondrial changes antibodies |
9.4% |
| vitamin D metabolic process antibodies |
9.4% |
| cell-cell junction maintenance antibodies |
9.4% |
| pigment granule organization antibodies |
9.4% |
| subthalamus development antibodies |
9.4% |
| apoptotic signaling pathway antibodies |
9.3% |
| centromeric heterochromatin assembly antibodies |
9.3% |
| chromatin assembly antibodies |
9.3% |
| telomere assembly antibodies |
9.3% |
| endosome organization antibodies |
9.3% |
| homeostatic process antibodies |
9.3% |
| protein localization to microtubule antibodies |
9.3% |
| zinc ion import antibodies |
9.3% |
| ribosomal small subunit assembly antibodies |
9.3% |
| arsenite transport antibodies |
9.3% |
| histone arginine methylation antibodies |
9.3% |
| brain segmentation antibodies |
9.3% |
| hepatocyte cell migration antibodies |
9.2% |
| xenobiotic metabolic process antibodies |
9.2% |
| peptidyl-threonine phosphorylation antibodies |
9.2% |
| telomere maintenance antibodies |
9.2% |
| synaptic vesicle priming antibodies |
9.2% |
| spindle assembly antibodies |
9.2% |
| caveola assembly antibodies |
9.2% |
| stem cell development antibodies |
9.2% |
| histone deacetylation antibodies |
9.2% |
| ciliary or flagellar motility antibodies |
9.2% |
| DNA methylation antibodies |
9.2% |
| nuclear pore organization antibodies |
9.2% |
| vesicle transport along microtubule antibodies |
9.2% |
| protein targeting antibodies |
9.1% |
| apoptotic cell clearance antibodies |
9.1% |
| pyrimidine base metabolic process antibodies |
9.1% |
| glycogen catabolic process antibodies |
9.1% |
| isocitrate metabolic process antibodies |
9.1% |
| apoptosis involved in morphogenesis antibodies |
9.1% |
| epoxygenase P450 pathway antibodies |
9.1% |
| ER overload response antibodies |
9.1% |
| tight junction assembly antibodies |
9.1% |
| borate transmembrane transport antibodies |
9.1% |
| cellular lipid catabolic process antibodies |
9.1% |
| fucose metabolic process antibodies |
9.1% |
| peptidyl-threonine dephosphorylation antibodies |
9.1% |
| protein K63-linked deubiquitination antibodies |
9.1% |
| de novo pyrimidine base biosynthetic process antibodies |
9.1% |
| xylulose metabolic process antibodies |
9.1% |
| peptidyl-serine dephosphorylation antibodies |
9.1% |
| cellular response to alkyl hydroperoxide antibodies |
9.1% |
| N-acetylneuraminate biosynthetic process antibodies |
9.1% |
| constitutive protein ectodomain proteolysis antibodies |
9.1% |
| protein de-ADP-ribosylation antibodies |
9.1% |
| myeloid dendritic cell cytokine production antibodies |
9.0% |
| transforming growth factor beta receptor signaling pathway antibodies |
9.0% |
| myoblast proliferation antibodies |
9.0% |
| paracrine signaling antibodies |
9.0% |
| fat cell differentiation antibodies |
9.0% |
| base-excision repair antibodies |
9.0% |
| hepatocyte growth factor receptor signaling pathway antibodies |
9.0% |
| fatty acid metabolic process antibodies |
9.0% |
| triglyceride metabolic process antibodies |
9.0% |
| muscle cell fate specification antibodies |
9.0% |
| drug catabolic process antibodies |
8.9% |
| apical junction assembly antibodies |
8.9% |
| osteoblast proliferation antibodies |
8.9% |
| tryptophan metabolic process antibodies |
8.9% |
| lateral semicircular canal development antibodies |
8.9% |
| gliogenesis antibodies |
8.9% |
| spindle checkpoint antibodies |
8.9% |
| translesion synthesis antibodies |
8.9% |
| homocysteine metabolic process antibodies |
8.9% |
| endosome to lysosome transport antibodies |
8.9% |
| response to bacterial lipoprotein antibodies |
8.9% |
| somatic stem cell division antibodies |
8.9% |
| histone H3-K4 acetylation antibodies |
8.9% |
| diapedesis antibodies |
8.9% |
| blue light signaling pathway antibodies |
8.8% |
| mesodermal cell fate specification antibodies |
8.8% |
| sensory processing antibodies |
8.8% |
| mitotic sister chromatid cohesion antibodies |
8.8% |
| histone H3 deacetylation antibodies |
8.8% |
| mitotic cell cycle spindle assembly checkpoint antibodies |
8.8% |
| cellular zinc ion homeostasis antibodies |
8.8% |
| proteasome assembly antibodies |
8.8% |
| cementum mineralization antibodies |
8.8% |
| TOR signaling cascade antibodies |
8.8% |
| B cell homeostatic proliferation antibodies |
8.8% |
| circadian sleep/wake cycle antibodies |
8.7% |
| chronic inflammatory response antibodies |
8.7% |
| gephyrin clustering antibodies |
8.7% |
| response to insulin stimulus antibodies |
8.7% |
| copper ion export antibodies |
8.7% |
| beta-amyloid metabolic process antibodies |
8.7% |
| mucosal-associated lymphoid tissue development antibodies |
8.7% |
| monoubiquitinated protein deubiquitination antibodies |
8.7% |
| manganese ion transmembrane transport antibodies |
8.7% |
| cellular amino acid catabolic process antibodies |
8.7% |
| protein O-linked glycosylation via serine antibodies |
8.7% |
| intermediate mesodermal cell differentiation antibodies |
8.7% |
| lipid tube assembly antibodies |
8.7% |
| adherens junction assembly antibodies |
8.7% |
| carotene metabolic process antibodies |
8.7% |
| presynaptic membrane assembly antibodies |
8.6% |
| neutrophil homeostasis antibodies |
8.6% |
| osteoclast differentiation antibodies |
8.6% |
| insulin receptor signaling pathway antibodies |
8.6% |
| defense response antibodies |
8.6% |
| response to nematode antibodies |
8.6% |
| glucose catabolic process antibodies |
8.6% |
| synapse assembly antibodies |
8.6% |
| cholesterol efflux antibodies |
8.6% |
| asymmetric cell division antibodies |
8.6% |
| neuron fate specification antibodies |
8.6% |
| vocal learning antibodies |
8.6% |
| membrane raft localization antibodies |
8.5% |
| endothelial cell migration antibodies |
8.5% |
| cholesterol metabolic process antibodies |
8.5% |
| protein targeting to ER antibodies |
8.5% |
| defense response to fungus antibodies |
8.5% |
| spinal cord radial glial cell differentiation antibodies |
8.5% |
| protein complex disassembly antibodies |
8.5% |
| stem cell differentiation antibodies |
8.5% |
| telomere capping antibodies |
8.5% |
| epithelial cell fate commitment antibodies |
8.5% |
| cell cycle arrest antibodies |
8.5% |
| mitochondrial DNA repair antibodies |
8.5% |
| glucose homeostasis antibodies |
8.5% |
| cell cycle checkpoint antibodies |
8.5% |
| membrane protein ectodomain proteolysis antibodies |
8.5% |
| dopamine receptor signaling pathway antibodies |
8.4% |
| mitochondrial respiratory chain complex III assembly antibodies |
8.4% |
| microtubule organizing center organization antibodies |
8.4% |
| cell-cell signaling antibodies |
8.4% |
| anatomical structure development antibodies |
8.4% |
| focal adhesion assembly antibodies |
8.4% |
| DNA damage checkpoint antibodies |
8.4% |
| post-translational protein modification antibodies |
8.4% |
| cellular copper ion homeostasis antibodies |
8.4% |
| osteoclast proliferation antibodies |
8.4% |
| histone H4 acetylation antibodies |
8.4% |
| endocytic recycling antibodies |
8.4% |
| myeloid cell apoptosis antibodies |
8.4% |
| neuron fate commitment antibodies |
8.3% |
| aspartate catabolic process antibodies |
8.3% |
| left/right pattern formation antibodies |
8.3% |
| renal tubule morphogenesis antibodies |
8.3% |
| folic acid metabolic process antibodies |
8.3% |
| ectodermal cell fate commitment antibodies |
8.3% |
| glycerophospholipid biosynthetic process antibodies |
8.3% |
| hyaluronan catabolic process antibodies |
8.3% |
| polyubiquitinated misfolded protein transport antibodies |
8.3% |
| ADP catabolic process antibodies |
8.3% |
| nuclear pore complex assembly antibodies |
8.3% |
| astrocyte activation antibodies |
8.3% |
| RNA metabolic process antibodies |
8.3% |
| spinal cord oligodendrocyte cell differentiation antibodies |
8.3% |
| cellular homeostasis antibodies |
8.3% |
| retina homeostasis antibodies |
8.3% |
| complement activation, lectin pathway antibodies |
8.3% |
| cytotoxic T cell degranulation antibodies |
8.3% |
| prepulse inhibition antibodies |
8.3% |
| B cell homeostasis antibodies |
8.3% |
| protein peptidyl-prolyl isomerization antibodies |
8.3% |
| lung ciliated cell differentiation antibodies |
8.3% |
| microtubule-based process antibodies |
8.2% |
| vitamin D receptor signaling pathway antibodies |
8.2% |
| NADH metabolic process antibodies |
8.2% |
| synaptonemal complex organization antibodies |
8.2% |
| protein deacetylation antibodies |
8.2% |
| ammonia assimilation cycle antibodies |
8.2% |
| response to starvation antibodies |
8.2% |
| base-excision repair, gap-filling antibodies |
8.2% |
| musculoskeletal movement antibodies |
8.2% |
| mammary gland epithelial cell proliferation antibodies |
8.2% |
| DNA damage induced protein phosphorylation antibodies |
8.2% |
| glucose import antibodies |
8.2% |
| melanosome organization antibodies |
8.2% |
| double-strand break repair antibodies |
8.2% |
| cell migration antibodies |
8.1% |
| cytokine metabolic process antibodies |
8.1% |
| epidermal growth factor receptor signaling pathway antibodies |
8.1% |
| mesonephric tubule formation antibodies |
8.1% |
| cytokine-mediated signaling pathway antibodies |
8.1% |
| fatty acid homeostasis antibodies |
8.1% |
| immune system development antibodies |
8.1% |
| UV protection antibodies |
8.1% |
| myoblast migration antibodies |
8.1% |
| membrane raft organization antibodies |
8.1% |
| photoreceptor cell maintenance antibodies |
8.1% |
| brown fat cell differentiation antibodies |
8.1% |
| receptor catabolic process antibodies |
8.0% |
| mRNA metabolic process antibodies |
8.0% |
| extracellular matrix assembly antibodies |
8.0% |
| pronephric nephron tubule development antibodies |
8.0% |
| prostate gland stromal morphogenesis antibodies |
8.0% |
| 3-phosphoadenosine 5-phosphosulfate transport antibodies |
8.0% |
| renal vesicle induction antibodies |
8.0% |
| G0 to G1 transition antibodies |
8.0% |
| G1 to G0 transition antibodies |
8.0% |
| anterior semicircular canal development antibodies |
8.0% |
| sister chromatid segregation antibodies |
8.0% |
| vasculogenesis antibodies |
8.0% |
| protein targeting to mitochondrion antibodies |
8.0% |
| keratinocyte migration antibodies |
8.0% |
| cellular response to salt stress antibodies |
8.0% |
| membrane biogenesis antibodies |
8.0% |
| olfactory bulb interneuron differentiation antibodies |
7.9% |
| long-term memory antibodies |
7.9% |
| protein oligomerization antibodies |
7.9% |
| spongiotrophoblast differentiation antibodies |
7.9% |
| bone trabecula formation antibodies |
7.9% |
| amygdala development antibodies |
7.9% |
| response to reactive oxygen species antibodies |
7.9% |
| glucocorticoid receptor signaling pathway antibodies |
7.9% |
| response to oxidative stress antibodies |
7.9% |
| actin filament bundle assembly antibodies |
7.9% |
| interleukin-13 biosynthetic process antibodies |
7.9% |
| subpallium development antibodies |
7.9% |
| chromatin organization antibodies |
7.9% |
| DNA replication checkpoint antibodies |
7.9% |
| peroxisome membrane biogenesis antibodies |
7.9% |
| response to stress antibodies |
7.9% |
| metabolic process antibodies |
7.9% |
| cellular defense response antibodies |
7.9% |
| response to organic nitrogen antibodies |
7.8% |
| fatty acid catabolic process antibodies |
7.8% |
| iron-sulfur cluster assembly antibodies |
7.8% |
| protein palmitoylation antibodies |
7.8% |
| response to axon injury antibodies |
7.8% |
| cofactor metabolic process antibodies |
7.8% |
| cellular response to erythropoietin antibodies |
7.8% |
| ribosomal large subunit assembly antibodies |
7.8% |
| outer mitochondrial membrane organization antibodies |
7.8% |
| respiratory chain complex IV assembly antibodies |
7.8% |
| methylation antibodies |
7.7% |
| convergent extension antibodies |
7.7% |
| post-embryonic development antibodies |
7.7% |
| JAK-STAT cascade antibodies |
7.7% |
| inflammatory response antibodies |
7.7% |
| epithelial cell morphogenesis antibodies |
7.7% |
| AMP catabolic process antibodies |
7.7% |
| pyrimidine nucleoside catabolic process antibodies |
7.7% |
| cytokinetic cell separation antibodies |
7.7% |
| angiogenesis involved in wound healing antibodies |
7.7% |
| histone H3-K36 methylation antibodies |
7.7% |
| cell differentiation in hindbrain antibodies |
7.7% |
| cellular response to extracellular stimulus antibodies |
7.7% |
| visceral motor neuron differentiation antibodies |
7.7% |
| olfactory bulb interneuron development antibodies |
7.7% |
| regulatory T cell differentiation antibodies |
7.7% |
| posterior lateral line nerve development antibodies |
7.7% |
| cytokinesis, actomyosin contractile ring assembly antibodies |
7.7% |
| septum secundum development antibodies |
7.7% |
| early endosome to Golgi transport antibodies |
7.7% |
| sister chromatid cohesion antibodies |
7.7% |
| metanephric mesenchymal cell migration antibodies |
7.7% |
| N-terminal protein lipidation antibodies |
7.7% |
| transforming growth factor beta receptor complex assembly antibodies |
7.7% |
| plasma membrane repair antibodies |
7.7% |
| motor axon guidance antibodies |
7.7% |
| stress fiber assembly antibodies |
7.7% |
| tissue remodeling antibodies |
7.6% |
| fibril organization antibodies |
7.6% |
| lamellipodium assembly antibodies |
7.6% |
| cerebral cortex GABAergic interneuron differentiation antibodies |
7.6% |
| receptor metabolic process antibodies |
7.6% |
| JUN phosphorylation antibodies |
7.6% |
| mitochondrial genome maintenance antibodies |
7.6% |
| response to cold antibodies |
7.6% |
| developmental process antibodies |
7.6% |
| hematopoietic stem cell migration antibodies |
7.6% |
| glucocorticoid mediated signaling pathway antibodies |
7.6% |
| macrophage migration inhibitory factor signaling pathway antibodies |
7.6% |
| T-helper cell differentiation antibodies |
7.6% |
| activin receptor signaling pathway antibodies |
7.6% |
| glyoxylate metabolic process antibodies |
7.5% |
| acetate metabolic process antibodies |
7.5% |
| homologous chromosome segregation antibodies |
7.5% |
| mitotic centrosome separation antibodies |
7.5% |
| foramen ovale closure antibodies |
7.5% |
| glucose metabolic process antibodies |
7.5% |
| osteoblast development antibodies |
7.5% |
| cortical microtubule organization antibodies |
7.5% |
| centrosome duplication antibodies |
7.5% |
| signaling antibodies |
7.5% |
| endodermal digestive tract morphogenesis antibodies |
7.5% |
| Fc receptor mediated inhibitory signaling pathway antibodies |
7.5% |
| hepatic immune response antibodies |
7.5% |
| mitotic sister chromatid segregation antibodies |
7.5% |
| neuroblast development antibodies |
7.5% |
| endodermal cell fate determination antibodies |
7.5% |
| mitochondrial mRNA surveillance antibodies |
7.4% |
| fibroblast migration antibodies |
7.4% |
| cellular response to reactive oxygen species antibodies |
7.4% |
| axon guidance antibodies |
7.4% |
| cell fate determination antibodies |
7.4% |
| serotonin receptor signaling pathway antibodies |
7.4% |
| cytokinesis antibodies |
7.4% |
| sinoatrial node cell development antibodies |
7.4% |
| cell morphogenesis involved in differentiation antibodies |
7.4% |
| leucine catabolic process antibodies |
7.4% |
| bleb assembly antibodies |
7.4% |
| metaphase plate congression antibodies |
7.4% |
| epidermal cell fate specification antibodies |
7.4% |
| hydrogen peroxide metabolic process antibodies |
7.4% |
| synaptonemal complex disassembly antibodies |
7.4% |
| neuroligin clustering antibodies |
7.4% |
| histone phosphorylation antibodies |
7.4% |
| acute inflammatory response antibodies |
7.4% |
| long term synaptic depression antibodies |
7.4% |
| protein acetylation antibodies |
7.4% |
| nucleotide catabolic process antibodies |
7.4% |
| response to salt stress antibodies |
7.3% |
| pronephros development antibodies |
7.3% |
| myoblast development antibodies |
7.3% |
| endothelial cell proliferation antibodies |
7.3% |
| lymphocyte homeostasis antibodies |
7.3% |
| membrane raft polarization antibodies |
7.3% |
| ribosomal large subunit biogenesis antibodies |
7.3% |
| mechanosensory behavior antibodies |
7.3% |
| cellular response to peptidoglycan antibodies |
7.3% |
| cellular manganese ion homeostasis antibodies |
7.3% |
| cellular response to starvation antibodies |
7.3% |
| cardiac cell differentiation antibodies |
7.3% |
| cellular protein complex disassembly antibodies |
7.3% |
| bone mineralization antibodies |
7.3% |
| cerebral cortex tangential migration antibodies |
7.3% |
| plasma lipoprotein particle remodeling antibodies |
7.3% |
| opioid receptor signaling pathway antibodies |
7.3% |
| cellular response to stress antibodies |
7.3% |
| nuclear export antibodies |
7.3% |
| N-terminal protein myristoylation antibodies |
7.3% |
| lactate metabolic process antibodies |
7.3% |
| protein modification process antibodies |
7.3% |
| hepatocyte proliferation antibodies |
7.2% |
| long-chain fatty acid metabolic process antibodies |
7.2% |
| Notch receptor processing antibodies |
7.2% |
| smooth muscle cell migration antibodies |
7.2% |
| centrosome organization antibodies |
7.2% |
| nucleotide-excision repair, DNA damage recognition antibodies |
7.2% |
| actin nucleation antibodies |
7.2% |
| synaptic transmission, glutamatergic antibodies |
7.2% |
| single strand break repair antibodies |
7.2% |
| cell proliferation antibodies |
7.2% |
| epithelial structure maintenance antibodies |
7.2% |
| protein targeting to membrane antibodies |
7.2% |
| signal complex assembly antibodies |
7.2% |
| adipose tissue development antibodies |
7.2% |
| cilium morphogenesis antibodies |
7.2% |
| peptidyl-serine phosphorylation antibodies |
7.1% |
| mammary gland alveolus development antibodies |
7.1% |
| actin filament-based movement antibodies |
7.1% |
| methylglyoxal metabolic process antibodies |
7.1% |
| intra-S DNA damage checkpoint antibodies |
7.1% |
| 2-oxobutyrate biosynthetic process antibodies |
7.1% |
| neural plate axis specification antibodies |
7.1% |
| UMP biosynthetic process antibodies |
7.1% |
| mitochondrial tyrosyl-tRNA aminoacylation antibodies |
7.1% |
| L-cysteine catabolic process antibodies |
7.1% |
| fear response antibodies |
7.1% |
| protein methylation antibodies |
7.1% |
| transcytosis antibodies |
7.1% |
| enzyme linked receptor protein signaling pathway antibodies |
7.1% |
| epithelial cell proliferation antibodies |
7.1% |
| membrane protein intracellular domain proteolysis antibodies |
7.1% |
| directional locomotion antibodies |
7.1% |
| G-protein coupled receptor internalization antibodies |
7.1% |
| TNFSF11-mediated signaling pathway antibodies |
7.1% |
| inner cell mass cell proliferation antibodies |
7.1% |
| response to other organism antibodies |
7.1% |
| nucleus accumbens development antibodies |
7.1% |
| nuclear pore distribution antibodies |
7.1% |
| RNA methylation antibodies |
7.0% |
| fucosylation antibodies |
7.0% |
| nicotinamide metabolic process antibodies |
7.0% |
| exploration behavior antibodies |
7.0% |
| intestinal epithelial structure maintenance antibodies |
7.0% |
| cell-substrate adhesion antibodies |
7.0% |
| muscle cell apoptosis antibodies |
7.0% |
| asymmetric protein localization antibodies |
7.0% |
| lens fiber cell morphogenesis antibodies |
7.0% |
| voluntary musculoskeletal movement antibodies |
7.0% |
| cellular response to vitamin K antibodies |
7.0% |
| response to aluminum ion antibodies |
7.0% |
| lung alveolus development antibodies |
7.0% |
| transcription-coupled nucleotide-excision repair antibodies |
7.0% |
| cerebral cortex GABAergic interneuron migration antibodies |
7.0% |
| heparin metabolic process antibodies |
7.0% |
| neutrophil apoptosis antibodies |
7.0% |
| chylomicron assembly antibodies |
7.0% |
| protein metabolic process antibodies |
7.0% |
| gamma-aminobutyric acid receptor clustering antibodies |
7.0% |
| T cell receptor signaling pathway antibodies |
7.0% |
| G-protein coupled receptor signaling pathway antibodies |
7.0% |
| mitotic cell cycle checkpoint antibodies |
6.9% |
| lipid homeostasis antibodies |
6.9% |
| fatty acid elongation, monounsaturated fatty acid antibodies |
6.9% |
| pseudopodium assembly antibodies |
6.9% |
| chondrocyte proliferation antibodies |
6.9% |
| collagen fibril organization antibodies |
6.9% |
| viral infectious cycle antibodies |
6.9% |
| synaptic vesicle maturation antibodies |
6.9% |
| C-terminal protein methylation antibodies |
6.9% |
| chondrocyte differentiation antibodies |
6.9% |
| 2-oxoglutarate metabolic process antibodies |
6.9% |
| cellular response to growth factor stimulus antibodies |
6.9% |
| double-strand break repair via homologous recombination antibodies |
6.9% |
| response to auditory stimulus antibodies |
6.9% |
| S-adenosylmethionine metabolic process antibodies |
6.9% |
| ERK5 cascade antibodies |
6.9% |
| Tie receptor signaling pathway antibodies |
6.9% |
| vascular endothelial growth factor production antibodies |
6.9% |
| astrocyte cell migration antibodies |
6.9% |
| retinoic acid receptor signaling pathway antibodies |
6.9% |
| defense response to bacterium antibodies |
6.8% |
| protein complex assembly antibodies |
6.8% |
| G2/M transition checkpoint antibodies |
6.8% |
| memory antibodies |
6.8% |
| demethylation antibodies |
6.8% |
| vesicle-mediated transport antibodies |
6.8% |
| endothelial cell development antibodies |
6.8% |
| cell death antibodies |
6.8% |
| chaperone-mediated protein folding antibodies |
6.8% |
| glyceraldehyde-3-phosphate metabolic process antibodies |
6.8% |
| peripheral nervous system myelin maintenance antibodies |
6.8% |
| nephric duct morphogenesis antibodies |
6.8% |
| histone H2A acetylation antibodies |
6.8% |
| dendritic cell chemotaxis antibodies |
6.8% |
| blood vessel remodeling antibodies |
6.8% |
| borate transport antibodies |
6.8% |
| myelin maintenance antibodies |
6.8% |
| heat generation antibodies |
6.8% |
| mammary gland bud formation antibodies |
6.8% |
| cellular response to oxidative stress antibodies |
6.8% |
| histone-serine phosphorylation antibodies |
6.8% |
| cellular metabolic process antibodies |
6.8% |
| myelination antibodies |
6.8% |
| immune system process antibodies |
6.8% |
| complement receptor mediated signaling pathway antibodies |
6.8% |
| DNA topological change antibodies |
6.8% |
| pericardium morphogenesis antibodies |
6.8% |
| microspike assembly antibodies |
6.8% |
| flavonoid glucuronidation antibodies |
6.7% |
| receptor clustering antibodies |
6.7% |
| central nervous system myelination antibodies |
6.7% |
| filopodium assembly antibodies |
6.7% |
| creatinine metabolic process antibodies |
6.7% |
| nucleotide-excision repair antibodies |
6.7% |
| myeloid dendritic cell differentiation antibodies |
6.7% |
| pyruvate metabolic process antibodies |
6.7% |
| lipid catabolic process antibodies |
6.7% |
| hepatocyte differentiation antibodies |
6.7% |
| glutamine metabolic process antibodies |
6.7% |
| centrosome cycle antibodies |
6.7% |
| odontoblast differentiation antibodies |
6.7% |
| agmatine biosynthetic process antibodies |
6.7% |
| arginine biosynthetic process via ornithine antibodies |
6.7% |
| positive regulation vascular endothelial growth factor production antibodies |
6.7% |
| chondroblast differentiation antibodies |
6.7% |
| hormone-mediated signaling pathway antibodies |
6.7% |
| transmembrane receptor protein serine/threonine kinase signaling pathway antibodies |
6.7% |
| open tracheal system development antibodies |
6.7% |
| arginine catabolic process antibodies |
6.7% |
| autophagic vacuole assembly antibodies |
6.7% |
| trabecula morphogenesis antibodies |
6.7% |
| defense response to virus antibodies |
6.7% |
| protein heterotrimerization antibodies |
6.7% |
| post-embryonic organ morphogenesis antibodies |
6.7% |
| cellular response to peptide hormone stimulus antibodies |
6.7% |
| tetrahydrofolate metabolic process antibodies |
6.7% |
| COPI-coated vesicle budding antibodies |
6.7% |
| wound healing involved in inflammatory response antibodies |
6.7% |
| rhodopsin mediated signaling pathway antibodies |
6.7% |
| cell proliferation in midbrain antibodies |
6.7% |
| age-dependent response to oxidative stress antibodies |
6.7% |
| myoblast cell differentiation involved in skeletal muscle regeneration antibodies |
6.7% |
| cell junction assembly antibodies |
6.7% |
| B cell apoptosis antibodies |
6.7% |
| intracellular estrogen receptor signaling pathway antibodies |
6.6% |
| enteric nervous system development antibodies |
6.6% |
| somite specification antibodies |
6.6% |
| neuron homeostasis antibodies |
6.6% |
| L-arginine import antibodies |
6.6% |
| cell dedifferentiation antibodies |
6.6% |
| protein destabilization antibodies |
6.6% |
| macrophage derived foam cell differentiation antibodies |
6.6% |
| virus-infected cell apoptosis antibodies |
6.6% |
| keratinocyte development antibodies |
6.6% |
| oxygen metabolic process antibodies |
6.6% |
| adult walking behavior antibodies |
6.6% |
| cell-cell junction assembly antibodies |
6.6% |
| snRNA transcription antibodies |
6.6% |
| S-adenosylmethioninamine metabolic process antibodies |
6.6% |
| endothelial cell activation antibodies |
6.6% |
| MAPK cascade antibodies |
6.6% |
| synapse maturation antibodies |
6.6% |
| cellular response to osmotic stress antibodies |
6.6% |
| endodermal cell differentiation antibodies |
6.6% |
| nitric oxide metabolic process antibodies |
6.6% |
| nuclear envelope organization antibodies |
6.6% |
| T-helper 1 cell differentiation antibodies |
6.6% |
| muscle cell homeostasis antibodies |
6.6% |
| flagellum assembly antibodies |
6.6% |
| bone remodeling antibodies |
6.5% |
| cellular cadmium ion homeostasis antibodies |
6.5% |
| epithelial cell development antibodies |
6.5% |
| SMAD protein signal transduction antibodies |
6.5% |
| fibroblast growth factor receptor signaling pathway antibodies |
6.5% |
| tendon development antibodies |
6.5% |
| vacuolar acidification antibodies |
6.5% |
| intestinal epithelial cell development antibodies |
6.5% |
| taurine metabolic process antibodies |
6.5% |
| mitotic cell cycle spindle checkpoint antibodies |
6.5% |
| T-helper 2 cell differentiation antibodies |
6.5% |
| astrocyte development antibodies |
6.5% |
| tachykinin receptor signaling pathway antibodies |
6.5% |
| B cell receptor signaling pathway antibodies |
6.5% |
| phospholipid homeostasis antibodies |
6.5% |
| histone H3-K4 methylation antibodies |
6.5% |
| synaptic vesicle endocytosis antibodies |
6.5% |
| receptor guanylyl cyclase signaling pathway antibodies |
6.5% |
| citrate metabolic process antibodies |
6.5% |
| DNA double-strand break processing antibodies |
6.5% |
| sebaceous gland development antibodies |
6.5% |
| dentate gyrus development antibodies |
6.5% |
| immune response antibodies |
6.5% |
| melanosome localization antibodies |
6.5% |
| cytoskeleton-dependent intracellular transport antibodies |
6.5% |
| cell differentiation in spinal cord antibodies |
6.4% |
| tissue homeostasis antibodies |
6.4% |
| axonogenesis antibodies |
6.4% |
| microtubule-based movement antibodies |
6.4% |
| SNARE complex disassembly antibodies |
6.4% |
| microtubule nucleation antibodies |
6.4% |
| endothelial cell morphogenesis antibodies |
6.4% |
| tricarboxylic acid cycle antibodies |
6.4% |
| histone dephosphorylation antibodies |
6.4% |
| cardiac muscle tissue regeneration antibodies |
6.4% |
| axis specification antibodies |
6.4% |
| prostatic bud formation antibodies |
6.4% |
| endothelial cell differentiation antibodies |
6.4% |
| myoblast differentiation antibodies |
6.4% |
| macrophage apoptosis antibodies |
6.4% |
| L-serine metabolic process antibodies |
6.4% |
| T cell migration antibodies |
6.4% |
| alanyl-tRNA aminoacylation antibodies |
6.3% |
| protein demethylation antibodies |
6.3% |
| radial glial cell differentiation antibodies |
6.3% |
| endosome transport antibodies |
6.3% |
| chemosensory behavior antibodies |
6.3% |
| autocrine signaling antibodies |
6.3% |
| cellular protein metabolic process antibodies |
6.3% |
| keratinocyte activation antibodies |
6.3% |
| lymph node development antibodies |
6.3% |
| glutamate receptor signaling pathway antibodies |
6.3% |
| integrin-mediated signaling pathway antibodies |
6.3% |
| malate metabolic process antibodies |
6.3% |
| telomere formation via telomerase antibodies |
6.3% |
| phototransduction, visible light antibodies |
6.3% |
| axis elongation antibodies |
6.3% |
| superoxide metabolic process antibodies |
6.3% |
| hemangioblast cell differentiation antibodies |
6.3% |
| RNA modification antibodies |
6.3% |
| trunk segmentation antibodies |
6.3% |
| neurotransmitter receptor metabolic process antibodies |
6.3% |
| phagolysosome assembly antibodies |
6.3% |
| dopaminergic neuron differentiation antibodies |
6.3% |
| phosphorylation antibodies |
6.3% |
| corpus callosum development antibodies |
6.3% |
| protein repair antibodies |
6.3% |
| oligodendrocyte differentiation antibodies |
6.3% |
| desmosome assembly antibodies |
6.3% |
| programmed cell death antibodies |
6.3% |
| ARF protein signal transduction antibodies |
6.3% |
| mesodermal cell differentiation antibodies |
6.3% |
| smooth muscle cell differentiation antibodies |
6.3% |
| adherens junction organization antibodies |
6.3% |
| myoblast cell fate commitment antibodies |
6.3% |
| cellular response to glucose stimulus antibodies |
6.3% |
| cellular response to dsRNA antibodies |
6.3% |
| tolerance induction to self antigen antibodies |
6.3% |
| metanephric capsule development antibodies |
6.3% |
| primary lung bud formation antibodies |
6.3% |
| response to platinum ion antibodies |
6.3% |
| protein O-linked glycosylation via threonine antibodies |
6.3% |
| endodermal cell fate commitment antibodies |
6.3% |
| insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade antibodies |
6.3% |
| glycoside catabolic process antibodies |
6.3% |
| response to linoleic acid antibodies |
6.3% |
| hair follicle maturation antibodies |
6.3% |
| plasma kallikrein-kinin cascade antibodies |
6.3% |
| IMP metabolic process antibodies |
6.3% |
| Golgi to endosome transport antibodies |
6.3% |
| Golgi to transport vesicle transport antibodies |
6.3% |
| ADP metabolic process antibodies |
6.3% |
| lambdoid suture morphogenesis antibodies |
6.3% |
| striatal medium spiny neuron differentiation antibodies |
6.3% |
| spindle organization antibodies |
6.2% |
| gene expression antibodies |
6.2% |
| replicative senescence antibodies |
6.2% |
| sinoatrial node development antibodies |
6.2% |
| vesicle organization antibodies |
6.2% |
| M phase antibodies |
6.2% |
| leukocyte homeostasis antibodies |
6.2% |
| cardiac muscle cell proliferation antibodies |
6.2% |
| ventricular cardiac muscle cell differentiation antibodies |
6.2% |
| ribosome assembly antibodies |
6.2% |
| atrioventricular valve morphogenesis antibodies |
6.2% |
| cardiac cell fate determination antibodies |
6.2% |
| response to cobalamin antibodies |
6.2% |
| postsynaptic membrane assembly antibodies |
6.2% |
| RNA repair antibodies |
6.2% |
| mitotic spindle organization antibodies |
6.2% |
| chondrocyte hypertrophy antibodies |
6.2% |
| lung goblet cell differentiation antibodies |
6.2% |
| cAMP metabolic process antibodies |
6.2% |
| mitotic spindle stabilization antibodies |
6.2% |
| extraocular skeletal muscle development antibodies |
6.2% |
| mRNA modification antibodies |
6.1% |
| cell cycle process antibodies |
6.1% |
| endothelial tube morphogenesis antibodies |
6.1% |
| fibroblast apoptosis antibodies |
6.1% |
| glutamate metabolic process antibodies |
6.1% |
| sodium-independent organic anion transport antibodies |
6.1% |
| cardiac vascular smooth muscle cell differentiation antibodies |
6.1% |
| mitochondrial electron transport, cytochrome c to oxygen antibodies |
6.1% |
| nickel cation transport antibodies |
6.1% |
| behavioral fear response antibodies |
6.1% |
| long-term synaptic potentiation antibodies |
6.1% |
| retinal metabolic process antibodies |
6.1% |
| actin filament severing antibodies |
6.1% |
| replication fork arrest antibodies |
6.1% |
| lipid metabolic process antibodies |
6.1% |
| protein heterooligomerization antibodies |
6.1% |
| paramesonephric duct development antibodies |
6.1% |
| benzoate metabolic process antibodies |
6.1% |
| response to extracellular stimulus antibodies |
6.1% |
| divalent metal ion export antibodies |
6.1% |
| receptor recycling antibodies |
6.1% |
| retinal cone cell development antibodies |
6.1% |
| retinal ganglion cell axon guidance antibodies |
6.1% |
| dendrite morphogenesis antibodies |
6.1% |
| midgut development antibodies |
6.1% |
| ATP metabolic process antibodies |
6.1% |
| nuclear mRNA surveillance antibodies |
6.0% |
| nuclear import antibodies |
6.0% |
| astrocyte differentiation antibodies |
6.0% |
| nitric oxide mediated signal transduction antibodies |
6.0% |
| lysosome organization antibodies |
6.0% |
| T cell lineage commitment antibodies |
6.0% |
| response to redox state antibodies |
6.0% |
| gamete generation antibodies |
6.0% |
| behavioral defense response antibodies |
6.0% |
| apoptotic process antibodies |
6.0% |
| right lung development antibodies |
6.0% |
| hair cell differentiation antibodies |
6.0% |
| enteroendocrine cell differentiation antibodies |
6.0% |
| very-low-density lipoprotein particle assembly antibodies |
6.0% |
| endoplasmic reticulum calcium ion homeostasis antibodies |
6.0% |
| fungiform papilla development antibodies |
6.0% |
| platelet-derived growth factor receptor signaling pathway antibodies |
6.0% |
| startle response antibodies |
6.0% |
| associative learning antibodies |
6.0% |
| neuron migration antibodies |
6.0% |
| organ regeneration antibodies |
6.0% |
| Clara cell differentiation antibodies |
6.0% |
| aortic smooth muscle cell differentiation antibodies |
6.0% |
| muscle cell fate commitment antibodies |
6.0% |
| lipoprotein metabolic process antibodies |
6.0% |
| intracellular receptor mediated signaling pathway antibodies |
5.9% |
| peptide catabolic process antibodies |
5.9% |
| intramembranous ossification antibodies |
5.9% |
| fever generation antibodies |
5.9% |
| synaptic transmission, glycinergic antibodies |
5.9% |
| actin cytoskeleton reorganization antibodies |
5.9% |
| fatty acid elongation, saturated fatty acid antibodies |
5.9% |
| receptor internalization antibodies |
5.9% |
| adenosine receptor signaling pathway antibodies |
5.9% |
| glomerular filtration antibodies |
5.9% |
| membrane budding antibodies |
5.9% |
| retinol metabolic process antibodies |
5.9% |
| mesonephric tubule development antibodies |
5.9% |
| ureteric bud elongation antibodies |
5.9% |
| ruffle organization antibodies |
5.9% |
| box C/D snoRNP assembly antibodies |
5.9% |
| smooth endoplasmic reticulum calcium ion homeostasis antibodies |
5.9% |
| oligodendrocyte cell fate specification antibodies |
5.9% |
| nuclear migration along microfilament antibodies |
5.9% |
| oxidative single-stranded DNA demethylation antibodies |
5.9% |
| synaptic vesicle membrane organization antibodies |
5.9% |
| glucosylceramide biosynthetic process antibodies |
5.9% |
| NAD metabolic process antibodies |
5.9% |
| oncosis antibodies |
5.9% |
| protein arginylation antibodies |
5.9% |
| response to silicon dioxide antibodies |
5.9% |
| lateral ganglionic eminence cell proliferation antibodies |
5.9% |
| enamel mineralization antibodies |
5.9% |
| rhythmic process antibodies |
5.9% |
| mitochondrial fusion antibodies |
5.9% |
| chromosome segregation antibodies |
5.9% |
| mitotic cell cycle arrest antibodies |
5.9% |
| lung development antibodies |
5.8% |
| cellular protein complex assembly antibodies |
5.8% |
| sensory system development antibodies |
5.8% |
| mating behavior antibodies |
5.8% |
| cellular iron ion homeostasis antibodies |
5.8% |
| iron ion transmembrane transport antibodies |
5.8% |
| male germ cell proliferation antibodies |
5.8% |
| glycosaminoglycan metabolic process antibodies |
5.8% |
| nitrate metabolic process antibodies |
5.8% |
| renal system development antibodies |
5.8% |
| germinal center B cell differentiation antibodies |
5.8% |
| response to fungus antibodies |
5.8% |
| B cell proliferation antibodies |
5.8% |
| neuron apoptosis antibodies |
5.8% |
| extracellular matrix organization antibodies |
5.8% |
| protein phosphorylation antibodies |
5.8% |
| centrosome localization antibodies |
5.8% |
| short-term memory antibodies |
5.8% |
| DNA modification antibodies |
5.8% |
| hair follicle development antibodies |
5.8% |
| disaccharide metabolic process antibodies |
5.8% |
| Malpighian tubule morphogenesis antibodies |
5.8% |
| renal interstitial cell development antibodies |
5.8% |
| cell-matrix adhesion antibodies |
5.8% |
| fat pad development antibodies |
5.8% |
| nitric oxide homeostasis antibodies |
5.8% |
| response to yeast antibodies |
5.8% |
| iron ion homeostasis antibodies |
5.8% |
| short-chain fatty acid biosynthetic process antibodies |
5.8% |
| stem cell division antibodies |
5.8% |
| sphingosine biosynthetic process antibodies |
5.8% |
| anaphase antibodies |
5.8% |
| smooth muscle cell proliferation antibodies |
5.8% |
| nephric duct formation antibodies |
5.8% |
| acetaldehyde metabolic process antibodies |
5.8% |
| vascular wound healing antibodies |
5.8% |
| DNA repair antibodies |
5.8% |
| I-kappaB phosphorylation antibodies |
5.8% |
| hepatic duct development antibodies |
5.7% |
| lacrimal gland development antibodies |
5.7% |
| transsulfuration antibodies |
5.7% |
| DNA recombinase assembly antibodies |
5.7% |
| cardiac muscle cell differentiation antibodies |
5.7% |
| fibroblast proliferation antibodies |
5.7% |
| receptor transactivation antibodies |
5.7% |
| inner cell mass cell differentiation antibodies |
5.7% |
| adult somatic muscle development antibodies |
5.7% |
| cell development antibodies |
5.7% |
| actin filament organization antibodies |
5.7% |
| plasma membrane organization antibodies |
5.7% |
| glial cell apoptosis antibodies |
5.7% |
| fatty acid elongation antibodies |
5.7% |
| keratinocyte proliferation antibodies |
5.7% |
| cellular response to hormone stimulus antibodies |
5.7% |
| germ cell programmed cell death antibodies |
5.7% |
| threonyl-tRNA aminoacylation antibodies |
5.7% |
| transcription elongation, DNA-dependent antibodies |
5.7% |
| JNK cascade antibodies |
5.7% |
| lipid particle organization antibodies |
5.7% |
| lung cell differentiation antibodies |
5.7% |
| developmental pigmentation antibodies |
5.7% |
| bone marrow development antibodies |
5.7% |
| response to biotin antibodies |
5.7% |
| type 2 immune response antibodies |
5.7% |
| cellular response to oxygen levels antibodies |
5.7% |
| cell cycle cytokinesis antibodies |
5.7% |
| cardiac muscle cell myoblast differentiation antibodies |
5.7% |
| male mating behavior antibodies |
5.7% |
| lung growth antibodies |
5.7% |
| DNA ligation antibodies |
5.7% |
| vesicle targeting antibodies |
5.7% |
| signal transduction antibodies |
5.7% |
| response to peptidoglycan antibodies |
5.7% |
| dopamine metabolic process antibodies |
5.7% |
| protein localization to chromosome antibodies |
5.7% |
| histidyl-tRNA aminoacylation antibodies |
5.7% |
| death antibodies |
5.7% |
| protein stabilization antibodies |
5.7% |
| cofactor transport antibodies |
5.7% |
| necrotic cell death antibodies |
5.7% |
| RNA capping antibodies |
5.7% |
| transmembrane receptor protein tyrosine kinase signaling pathway antibodies |
5.6% |
| actin cytoskeleton organization antibodies |
5.6% |
| sperm chromatin condensation antibodies |
5.6% |
| pattern specification process antibodies |
5.6% |
| proteoglycan metabolic process antibodies |
5.6% |
| nephrogenic mesenchyme morphogenesis antibodies |
5.6% |
| sinus venosus morphogenesis antibodies |
5.6% |
| carnosine biosynthetic process antibodies |
5.6% |
| epithelial tube morphogenesis antibodies |
5.6% |
| lipid storage antibodies |
5.6% |
| growth hormone receptor signaling pathway antibodies |
5.6% |
| cell cycle antibodies |
5.6% |
| cyclooxygenase pathway antibodies |
5.6% |
| chondrocyte development antibodies |
5.6% |
| protein hexamerization antibodies |
5.6% |
| mRNA stabilization antibodies |
5.6% |
| DNA metabolic process antibodies |
5.6% |
| long-chain fatty-acyl-CoA biosynthetic process antibodies |
5.6% |
| Golgi inheritance antibodies |
5.6% |
| hair follicle morphogenesis antibodies |
5.6% |
| protein-DNA complex assembly antibodies |
5.6% |
| memory T cell activation antibodies |
5.6% |
| skeletal system development antibodies |
5.6% |
| ionotropic glutamate receptor signaling pathway antibodies |
5.6% |
| cellular process antibodies |
5.6% |
| hippocampus development antibodies |
5.6% |
| sleep antibodies |
5.6% |
| tRNA modification antibodies |
5.6% |
| protein unfolding antibodies |
5.6% |
| protein polymerization antibodies |
5.6% |
| epithelial cell-cell adhesion antibodies |
5.6% |
| Schwann cell proliferation antibodies |
5.6% |
| mast cell activation antibodies |
5.6% |
| triglyceride catabolic process antibodies |
5.6% |
| fructose 1,6-bisphosphate metabolic process antibodies |
5.6% |
| phosphatidylinositol metabolic process antibodies |
5.6% |
| cellular response to nutrient levels antibodies |
5.6% |
| response to growth factor stimulus antibodies |
5.6% |
| response to monosaccharide stimulus antibodies |
5.6% |
| mesodermal cell fate determination antibodies |
5.6% |
| myeloid dendritic cell chemotaxis antibodies |
5.6% |
| deoxynucleotide transport antibodies |
5.6% |
| DNA replication-dependent nucleosome assembly antibodies |
5.6% |
| cell proliferation in hindbrain antibodies |
5.6% |
| leading edge cell differentiation antibodies |
5.6% |
| skeletal muscle atrophy antibodies |
5.6% |
| face development antibodies |
5.5% |
| acetyl-CoA biosynthetic process antibodies |
5.5% |
| integrin activation antibodies |
5.5% |
| cellular component assembly antibodies |
5.5% |
| protein localization to nucleus antibodies |
5.5% |
| liver development antibodies |
5.5% |
| mating antibodies |
5.5% |
| germ cell development antibodies |
5.5% |
| neuron fate determination antibodies |
5.5% |
| dendritic cell differentiation antibodies |
5.5% |
| response to superoxide antibodies |
5.5% |
| protein complex localization antibodies |
5.5% |
| protein adenylylation antibodies |
5.5% |
| otic vesicle development antibodies |
5.5% |
| response to ATP antibodies |
5.5% |
| serotonin metabolic process antibodies |
5.5% |
| gap junction assembly antibodies |
5.5% |
| GPI anchor release antibodies |
5.5% |
| glial cell migration antibodies |
5.5% |
| germinal center formation antibodies |
5.5% |
| sensory organ development antibodies |
5.5% |
| glycoprotein metabolic process antibodies |
5.5% |
| commissural neuron axon guidance antibodies |
5.5% |
| blood vessel maturation antibodies |
5.5% |
| inner ear receptor cell differentiation antibodies |
5.5% |
| vesicle localization antibodies |
5.5% |
| CD8-positive, alpha-beta T cell proliferation antibodies |
5.5% |
| hydrogen sulfide biosynthetic process antibodies |
5.5% |
| rRNA processing antibodies |
5.5% |
| respiratory system process antibodies |
5.5% |
| mismatch repair antibodies |
5.5% |
| actin-myosin filament sliding antibodies |
5.5% |
| response to pyrethroid antibodies |
5.5% |
| ISG15-protein conjugation antibodies |
5.5% |
| maternal placenta development antibodies |
5.5% |
| skin development antibodies |
5.4% |
| cholesterol import antibodies |
5.4% |
| photoreceptor cell outer segment organization antibodies |
5.4% |
| uridine metabolic process antibodies |
5.4% |
| neurological system process antibodies |
5.4% |
| response to X-ray antibodies |
5.4% |
| arachidonic acid metabolic process antibodies |
5.4% |
| glial cell proliferation antibodies |
5.4% |
| NK T cell proliferation antibodies |
5.4% |
| cellular response to triglyceride antibodies |
5.4% |
| urea transmembrane transport antibodies |
5.4% |
| globus pallidus development antibodies |
5.4% |
| digestive tract morphogenesis antibodies |
5.4% |
| actin modification antibodies |
5.4% |
| single fertilization antibodies |
5.4% |
| response to methanol antibodies |
5.4% |
| primary sex determination antibodies |
5.4% |
| type B pancreatic cell differentiation antibodies |
5.4% |
| post-embryonic body morphogenesis antibodies |
5.4% |
| zonula adherens maintenance antibodies |
5.4% |
| response to dsRNA antibodies |
5.4% |
| metanephric nephron tubule morphogenesis antibodies |
5.4% |
| glucosamine metabolic process antibodies |
5.4% |
| epithelial tube formation antibodies |
5.4% |
| glutathione metabolic process antibodies |
5.4% |
| marginal zone B cell differentiation antibodies |
5.4% |
| oxidative phosphorylation antibodies |
5.4% |
| vitamin metabolic process antibodies |
5.4% |
| tRNA 3-end processing antibodies |
5.4% |
| nephron tubule morphogenesis antibodies |
5.4% |
| germ cell migration antibodies |
5.4% |
| dendritic cell dendrite assembly antibodies |
5.4% |
| acylglycerol homeostasis antibodies |
5.4% |
| cognition antibodies |
5.4% |
| retinal pigment epithelium development antibodies |
5.4% |
| intrahepatic bile duct development antibodies |
5.4% |
| melanosome transport antibodies |
5.4% |
| actin polymerization or depolymerization antibodies |
5.4% |
| heterotypic cell-cell adhesion antibodies |
5.4% |
| mast cell degranulation antibodies |
5.4% |
| lactose biosynthetic process antibodies |
5.4% |
| tooth mineralization antibodies |
5.4% |
| D-xylose metabolic process antibodies |
5.4% |
| neuronal signal transduction antibodies |
5.4% |
| behavioral response to ethanol antibodies |
5.3% |
| atrioventricular valve development antibodies |
5.3% |
| mammary gland development antibodies |
5.3% |
| tube development antibodies |
5.3% |
| purinergic nucleotide receptor signaling pathway antibodies |
5.3% |
| heart valve morphogenesis antibodies |
5.3% |
| Golgi disassembly antibodies |
5.3% |
| sterol homeostasis antibodies |
5.3% |
| tRNA processing antibodies |
5.3% |
| cellular response to nutrient antibodies |
5.3% |
| retinal rod cell development antibodies |
5.3% |
| cytokine secretion antibodies |
5.3% |
| lung epithelial cell differentiation antibodies |
5.3% |
| cell surface receptor signaling pathway antibodies |
5.3% |
| regulated secretory pathway antibodies |
5.3% |
| smooth muscle cell-matrix adhesion antibodies |
5.3% |
| DNA synthesis involved in DNA repair antibodies |
5.3% |
| de novo protein folding antibodies |
5.3% |
| interleukin-8 secretion antibodies |
5.3% |
| cell-cell adhesion antibodies |
5.3% |
| cholesterol storage antibodies |
5.3% |
| leukemia inhibitory factor signaling pathway antibodies |
5.3% |
| peroxisome organization antibodies |
5.3% |
| cAMP-mediated signaling antibodies |
5.3% |
| endochondral ossification antibodies |
5.3% |
| collagen metabolic process antibodies |
5.3% |
| T cell proliferation antibodies |
5.3% |
| sarcomere organization antibodies |
5.3% |
| vacuole organization antibodies |
5.3% |
| nucleocytoplasmic transport antibodies |
5.3% |
| electron transport chain antibodies |
5.3% |
| cellular response to mycophenolic acid antibodies |
5.3% |
| substrate-dependent cell migration antibodies |
5.3% |
| segment specification antibodies |
5.3% |
| endocardial cushion formation antibodies |
5.3% |
| chondroitin sulfate metabolic process antibodies |
5.3% |
| hypochord development antibodies |
5.3% |
| nucleoside diphosphate metabolic process antibodies |
5.3% |
| mitotic anaphase antibodies |
5.3% |
| anterior region determination antibodies |
5.3% |
| skeletal muscle cell differentiation antibodies |
5.2% |
| female courtship behavior antibodies |
5.2% |
| brain development antibodies |
5.2% |
| zinc ion transport antibodies |
5.2% |
| histone H4 deacetylation antibodies |
5.2% |
| RNA destabilization antibodies |
5.2% |
| central nervous system development antibodies |
5.2% |
| synaptic vesicle exocytosis antibodies |
5.2% |
| muscle cell differentiation antibodies |
5.2% |
| neural nucleus development antibodies |
5.2% |
| Sertoli cell proliferation antibodies |
5.2% |
| fatty acid beta-oxidation antibodies |
5.2% |
| pericardium development antibodies |
5.2% |
| response to osmotic stress antibodies |
5.2% |
| diet induced thermogenesis antibodies |
5.2% |
| lymph vessel development antibodies |
5.2% |
| G-protein coupled acetylcholine receptor signaling pathway antibodies |
5.2% |
| small GTPase mediated signal transduction antibodies |
5.2% |
| calcium-mediated signaling antibodies |
5.2% |
| cellular protein complex localization antibodies |
5.2% |
| neural crest cell development antibodies |
5.2% |
| primary follicle stage antibodies |
5.2% |
| male meiosis sister chromatid cohesion antibodies |
5.2% |
| nail development antibodies |
5.2% |
| hard palate development antibodies |
5.2% |
| tube formation antibodies |
5.2% |
| cytoskeleton organization antibodies |
5.2% |
| RNA processing antibodies |
5.2% |
| cellular response to cAMP antibodies |
5.2% |
| sensitization antibodies |
5.2% |
| acyl-CoA metabolic process antibodies |
5.2% |
| metanephric nephron tubule formation antibodies |
5.2% |
| axonal fasciculation antibodies |
5.2% |
| plasma lipoprotein particle oxidation antibodies |
5.2% |
| lysosomal transport antibodies |
5.2% |
| microtubule anchoring antibodies |
5.2% |
| metanephric mesenchyme morphogenesis antibodies |
5.2% |
| proline transmembrane transport antibodies |
5.2% |
| ossification antibodies |
5.2% |
| error-prone translesion synthesis antibodies |
5.2% |
| Rho protein signal transduction antibodies |
5.1% |
| cellular cation homeostasis antibodies |
5.1% |
| intracellular steroid hormone receptor signaling pathway antibodies |
5.1% |
| immune response to tumor cell antibodies |
5.1% |
| cell envelope organization antibodies |
5.1% |
| heart development antibodies |
5.1% |
| phagocytosis, recognition antibodies |
5.1% |
| fatty acid biosynthetic process antibodies |
5.1% |
| prostate gland morphogenesis antibodies |
5.1% |
| protein N-linked glycosylation via asparagine antibodies |
5.1% |
| methylation-dependent chromatin silencing antibodies |
5.1% |
| hemoglobin metabolic process antibodies |
5.1% |
| O-glycan processing antibodies |
5.1% |
| olfactory learning antibodies |
5.1% |
| digestive tract development antibodies |
5.1% |
| cell recognition antibodies |
5.1% |
| cellular phosphate ion homeostasis antibodies |
5.1% |
| protein tetramerization antibodies |
5.1% |
| microtubule polymerization antibodies |
5.1% |
| cellular amino acid metabolic process antibodies |
5.1% |
| basement membrane assembly antibodies |
5.1% |
| DNA packaging antibodies |
5.1% |
| protein refolding antibodies |
5.1% |
| type B pancreatic cell proliferation antibodies |
5.1% |
| proline metabolic process antibodies |
5.1% |
| neuron death antibodies |
5.1% |
| renal tubule development antibodies |
5.1% |
| collecting duct development antibodies |
5.1% |
| T-helper 1 type immune response antibodies |
5.1% |
| beta-amyloid formation antibodies |
5.1% |
| endocardial cushion development antibodies |
5.1% |
| mitotic spindle elongation antibodies |
5.1% |
| ureter urothelium development antibodies |
5.1% |
| peptide metabolic process antibodies |
5.1% |
| otic placode formation antibodies |
5.1% |
| response to hypoxia antibodies |
5.1% |
| lateral ventricle development antibodies |
5.1% |
| carboxylic acid metabolic process antibodies |
5.1% |
| neuron differentiation antibodies |
5.1% |
| glial cell fate determination antibodies |
5.1% |
| cell adhesion antibodies |
5.1% |
| steroid hormone mediated signaling pathway antibodies |
5.1% |
| B cell lineage commitment antibodies |
5.1% |
| sulfate assimilation antibodies |
5.0% |
| oxidation-reduction process antibodies |
5.0% |
| transformed cell apoptosis antibodies |
5.0% |
| drug export antibodies |
5.0% |
| reproductive process antibodies |
5.0% |
| bile acid metabolic process antibodies |
5.0% |
| response to oleic acid antibodies |
5.0% |
| actin filament polymerization antibodies |
5.0% |
| retinal blood vessel morphogenesis antibodies |
5.0% |
| dephosphorylation antibodies |
5.0% |
| cell activation antibodies |
5.0% |
| endothelial cell-cell adhesion antibodies |
5.0% |
| somatic muscle development antibodies |
5.0% |
| neural crest cell migration antibodies |
5.0% |
| mitotic cell cycle DNA replication checkpoint antibodies |
5.0% |
| respiratory system development antibodies |
5.0% |
| growth plate cartilage chondrocyte proliferation antibodies |
5.0% |
| pancreas development antibodies |
5.0% |
| synaptic transmission, GABAergic antibodies |
5.0% |
| polysaccharide metabolic process antibodies |
5.0% |
| chemical homeostasis antibodies |
5.0% |
| phospholipid catabolic process antibodies |
5.0% |
| response to nickel cation antibodies |
5.0% |
| retinoic acid metabolic process antibodies |
5.0% |
| histone H3-K4 demethylation antibodies |
5.0% |
| metanephric interstitial cell development antibodies |
5.0% |
| pigment granule localization antibodies |
5.0% |
| inter-male aggressive behavior antibodies |
5.0% |
| cell differentiation antibodies |
5.0% |
| mitochondrial DNA replication antibodies |
5.0% |
| oocyte maturation antibodies |
5.0% |
| beta selection antibodies |
5.0% |
| replicative cell aging antibodies |
5.0% |
| leukocyte tethering or rolling antibodies |
5.0% |
| water transport antibodies |
5.0% |
| protein localization to organelle antibodies |
5.0% |
| neuron maturation antibodies |
5.0% |
| acute-phase response antibodies |
5.0% |
| meiotic spindle organization antibodies |
5.0% |
| oocyte development antibodies |
5.0% |
| cellular response to interleukin-6 antibodies |
5.0% |
| otic vesicle formation antibodies |
5.0% |
| neural tube closure antibodies |
5.0% |
| tubulin complex assembly antibodies |
5.0% |
| retinal bipolar neuron differentiation antibodies |
5.0% |
| macrophage activation antibodies |
5.0% |
| tissue development antibodies |
5.0% |
| nephrogenic mesenchyme development antibodies |
5.0% |
| myoblast cell fate determination antibodies |
5.0% |
| leucyl-tRNA aminoacylation antibodies |
5.0% |
| S-adenosylmethionine biosynthetic process antibodies |
4.9% |
| meiotic prophase II antibodies |
4.9% |
| head development antibodies |
4.9% |
| developmental growth antibodies |
4.9% |
| lactate transmembrane transport antibodies |
4.9% |
| lung induction antibodies |
4.9% |
| nervous system development antibodies |
4.9% |
| cellular response to X-ray antibodies |
4.9% |
| mitotic metaphase/anaphase transition antibodies |
4.9% |
| fatty acid elongation, polyunsaturated fatty acid antibodies |
4.9% |
| ribosome disassembly antibodies |
4.9% |
| organic cation transport antibodies |
4.9% |
| autophagic vacuole fusion antibodies |
4.9% |
| organ development antibodies |
4.9% |
| vesicle fusion antibodies |
4.9% |
| glycoprotein catabolic process antibodies |
4.9% |
| response to pain antibodies |
4.9% |
| mitotic cell cycle antibodies |
4.9% |
| cell maturation antibodies |
4.9% |
| gonadal mesoderm development antibodies |
4.9% |
| cellular response to ATP antibodies |
4.9% |
| neural crest cell differentiation antibodies |
4.9% |
| connective tissue growth factor biosynthetic process antibodies |
4.9% |
| substantia nigra development antibodies |
4.9% |
| rRNA methylation antibodies |
4.9% |
| muscle structure development antibodies |
4.9% |
| NADPH regeneration antibodies |
4.9% |
| peripheral nervous system axon regeneration antibodies |
4.9% |
| endoplasmic reticulum organization antibodies |
4.9% |
| D-serine transport antibodies |
4.9% |
| lysyl-tRNA aminoacylation antibodies |
4.9% |
| chemokine biosynthetic process antibodies |
4.9% |
| outer medullary collecting duct development antibodies |
4.9% |
| protein dephosphorylation antibodies |
4.9% |
| mammary gland involution antibodies |
4.9% |
| tolerance induction antibodies |
4.9% |
| muscle atrophy antibodies |
4.9% |
| cardiovascular system development antibodies |
4.9% |
| spliceosomal snRNP assembly antibodies |
4.9% |
| forebrain radial glial cell differentiation antibodies |
4.9% |
| somitogenesis antibodies |
4.9% |
| follicle-stimulating hormone signaling pathway antibodies |
4.9% |
| epidermis development antibodies |
4.9% |
| glial cell differentiation antibodies |
4.8% |
| threonine biosynthetic process antibodies |
4.8% |
| ventral midline development antibodies |
4.8% |
| protein folding antibodies |
4.8% |
| cytokine production antibodies |
4.8% |
| learning antibodies |
4.8% |
| neuron development antibodies |
4.8% |
| natural killer cell proliferation antibodies |
4.8% |
| RNA transport antibodies |
4.8% |
| salivary gland development antibodies |
4.8% |
| myelin assembly antibodies |
4.8% |
| RNA polymerase II transcriptional preinitiation complex assembly antibodies |
4.8% |
| amino sugar metabolic process antibodies |
4.8% |
| interleukin-8 production antibodies |
4.8% |
| methionine metabolic process antibodies |
4.8% |
| N-glycan processing antibodies |
4.8% |
| cellular component organization antibodies |
4.8% |
| protein kinase B signaling cascade antibodies |
4.8% |
| neural retina development antibodies |
4.8% |
| developmental programmed cell death antibodies |
4.8% |
| respiratory tube development antibodies |
4.8% |
| wax biosynthetic process antibodies |
4.8% |
| mammary gland epithelial cell differentiation antibodies |
4.8% |
| T-helper 1 cell cytokine production antibodies |
4.8% |
| embryonic axis specification antibodies |
4.8% |
| response to hydrogen peroxide antibodies |
4.8% |
| bronchiole development antibodies |
4.8% |
| angiotensin maturation antibodies |
4.8% |
| developmental induction antibodies |
4.8% |
| endocardial cell differentiation antibodies |
4.8% |
| response to cAMP antibodies |
4.8% |
| ferrous iron transport antibodies |
4.8% |
| lipopolysaccharide transport antibodies |
4.8% |
| cortical actin cytoskeleton organization antibodies |
4.8% |
| tyrosine metabolic process antibodies |
4.8% |
| polarized epithelial cell differentiation antibodies |
4.8% |
| xenobiotic transport antibodies |
4.8% |
| cellular hyperosmotic response antibodies |
4.8% |
| monocyte activation antibodies |
4.8% |
| glomerulus morphogenesis antibodies |
4.8% |
| skeletal muscle tissue regeneration antibodies |
4.8% |
| developmental cell growth antibodies |
4.8% |
| tissue regeneration antibodies |
4.8% |
| response to nitrosative stress antibodies |
4.8% |
| retinoid metabolic process antibodies |
4.8% |
| response to vitamin K antibodies |
4.8% |
| spinal cord oligodendrocyte cell fate specification antibodies |
4.8% |
| response to iron(III) ion antibodies |
4.8% |
| long-chain fatty acid biosynthetic process antibodies |
4.8% |
| axonemal dynein complex assembly antibodies |
4.8% |
| glycerol-3-phosphate metabolic process antibodies |
4.8% |
| pyrimidine nucleotide metabolic process antibodies |
4.8% |
| phosphatidylserine metabolic process antibodies |
4.8% |
| somatic motor neuron differentiation antibodies |
4.8% |
| response to interleukin-11 antibodies |
4.8% |
| rRNA transport antibodies |
4.8% |
| ureteric bud development antibodies |
4.8% |
| surfactant homeostasis antibodies |
4.7% |
| learning or memory antibodies |
4.7% |
| mast cell proliferation antibodies |
4.7% |
| melatonin biosynthetic process antibodies |
4.7% |
| pyramidal neuron development antibodies |
4.7% |
| intracellular mRNA localization antibodies |
4.7% |
| visual behavior antibodies |
4.7% |
| wound healing antibodies |
4.7% |
| oviduct epithelium development antibodies |
4.7% |
| response to nutrient antibodies |
4.7% |
| epithelial cell differentiation antibodies |
4.7% |
| insulin processing antibodies |
4.7% |
| blastoderm segmentation antibodies |
4.7% |
| facial nucleus development antibodies |
4.7% |
| monocarboxylic acid transport antibodies |
4.7% |
| UDP biosynthetic process antibodies |
4.7% |
| cerebral cortex cell migration antibodies |
4.7% |
| renal system process antibodies |
4.7% |
| sodium-dependent organic cation transport antibodies |
4.7% |
| hair cycle antibodies |
4.7% |
| eating behavior antibodies |
4.7% |
| peripheral nervous system development antibodies |
4.7% |
| heart valve development antibodies |
4.7% |
| histone mRNA 3-end processing antibodies |
4.7% |
| mRNA 3-end processing antibodies |
4.7% |
| rhythmic behavior antibodies |
4.7% |
| cellular lipid metabolic process antibodies |
4.7% |
| microtubule cytoskeleton organization antibodies |
4.7% |
| intestinal epithelial cell maturation antibodies |
4.7% |
| T cell cytokine production antibodies |
4.7% |
| neuroepithelial cell differentiation antibodies |
4.7% |
| DNA protection antibodies |
4.7% |
| alcohol metabolic process antibodies |
4.7% |
| aggressive behavior antibodies |
4.7% |
| response to hydroperoxide antibodies |
4.7% |
| carbohydrate catabolic process antibodies |
4.7% |
| proteolysis antibodies |
4.7% |
| hormone metabolic process antibodies |
4.7% |
| lateral inhibition antibodies |
4.7% |
| endoplasmic reticulum localization antibodies |
4.7% |
| microtubule bundle formation antibodies |
4.7% |
| peptide antigen stabilization antibodies |
4.7% |
| olfactory behavior antibodies |
4.7% |
| mRNA cleavage antibodies |
4.7% |
| blood vessel endothelial cell migration antibodies |
4.7% |
| dendrite development antibodies |
4.7% |
| mitochondrion localization antibodies |
4.7% |
| mitotic prometaphase antibodies |
4.7% |
| activated T cell proliferation antibodies |
4.7% |
| acrosome assembly antibodies |
4.7% |
| defense response to tumor cell antibodies |
4.7% |
| Sertoli cell development antibodies |
4.7% |
| metanephric cortex development antibodies |
4.7% |
| actin filament capping antibodies |
4.6% |
| response to fatty acid antibodies |
4.6% |
| bone maturation antibodies |
4.6% |
| hindgut morphogenesis antibodies |
4.6% |
| fructose metabolic process antibodies |
4.6% |
| endoderm development antibodies |
4.6% |
| central nervous system neuron differentiation antibodies |
4.6% |
| behavioral response to pain antibodies |
4.6% |
| digestive tract mesoderm development antibodies |
4.6% |
| keratinocyte differentiation antibodies |
4.6% |
| response to food antibodies |
4.6% |
| inner ear development antibodies |
4.6% |
| locomotion antibodies |
4.6% |
| gastrulation antibodies |
4.6% |
| cysteine metabolic process antibodies |
4.6% |
| bone development antibodies |
4.6% |
| carbohydrate mediated signaling antibodies |
4.6% |
| response to nutrient levels antibodies |
4.6% |
| cellular response to nitric oxide antibodies |
4.6% |
| cellular extravasation antibodies |
4.6% |
| drug metabolic process antibodies |
4.6% |
| fatty acid oxidation antibodies |
4.6% |
| response to cobalt ion antibodies |
4.6% |
| G1 phase antibodies |
4.6% |
| xenobiotic glucuronidation antibodies |
4.6% |
| genetic imprinting antibodies |
4.6% |
| aerobic respiration antibodies |
4.6% |
| oxidative demethylation antibodies |
4.6% |
| protein processing antibodies |
4.6% |
| response to triglyceride antibodies |
4.6% |
| mitochondrial ATP synthesis coupled electron transport antibodies |
4.6% |
| protein mannosylation antibodies |
4.6% |
| apical protein localization antibodies |
4.6% |
| cartilage development antibodies |
4.6% |
| aortic valve morphogenesis antibodies |
4.6% |
| defecation antibodies |
4.6% |
| anagen antibodies |
4.6% |
| protein kinase C signaling cascade antibodies |
4.6% |
| artery development antibodies |
4.6% |
| sulfation antibodies |
4.6% |
| humoral immune response antibodies |
4.6% |
| spliceosome assembly antibodies |
4.6% |
| photoreceptor cell development antibodies |
4.5% |
| natural killer cell activation antibodies |
4.5% |
| ureter smooth muscle cell differentiation antibodies |
4.5% |
| spinal cord association neuron differentiation antibodies |
4.5% |
| aspartate metabolic process antibodies |
4.5% |
| histone H3-K9 demethylation antibodies |
4.5% |
| Golgi calcium ion homeostasis antibodies |
4.5% |
| actin rod assembly antibodies |
4.5% |
| mitotic cell cycle G2/M transition DNA damage checkpoint antibodies |
4.5% |
| galactose metabolic process antibodies |
4.5% |
| mitotic metaphase plate congression antibodies |
4.5% |
| cysteinyl-tRNA aminoacylation antibodies |
4.5% |
| histone exchange antibodies |
4.5% |
| preantral ovarian follicle growth antibodies |
4.5% |
| vascular smooth muscle cell development antibodies |
4.5% |
| reproductive structure development antibodies |
4.5% |
| antral ovarian follicle growth antibodies |
4.5% |
| phosphatidylinositol 3-kinase cascade antibodies |
4.5% |
| tongue development antibodies |
4.5% |
| postsynaptic membrane organization antibodies |
4.5% |
| catagen antibodies |
4.5% |
| kidney development antibodies |
4.5% |
| cell growth antibodies |
4.5% |
| photoreceptor cell morphogenesis antibodies |
4.5% |
| inner mitochondrial membrane organization antibodies |
4.5% |
| cellular response to vitamin D antibodies |
4.5% |
| lymphatic endothelial cell differentiation antibodies |
4.5% |
| heme O biosynthetic process antibodies |
4.5% |
| metanephric epithelium development antibodies |
4.5% |
| hydrogen peroxide biosynthetic process antibodies |
4.5% |
| cuticle development antibodies |
4.5% |
| cell morphogenesis antibodies |
4.5% |
| muscle cell fate determination antibodies |
4.5% |
| lymphoid progenitor cell differentiation antibodies |
4.5% |
| olfactory bulb development antibodies |
4.5% |
| auditory receptor cell differentiation antibodies |
4.5% |
| cell proliferation in forebrain antibodies |
4.5% |
| mRNA transport antibodies |
4.5% |
| DNA integration antibodies |
4.5% |
| triglyceride biosynthetic process antibodies |
4.5% |
| response to lead ion antibodies |
4.5% |
| sperm mitochondrion organization antibodies |
4.5% |
| endoderm formation antibodies |
4.5% |
| stomach neuroendocrine cell differentiation antibodies |
4.5% |
| RNA 3-end processing antibodies |
4.5% |
| intracellular signal transduction antibodies |
4.5% |
| protein localization antibodies |
4.5% |
| central tolerance induction antibodies |
4.5% |
| maternal aggressive behavior antibodies |
4.5% |
| cellular response to hydrogen peroxide antibodies |
4.5% |
| response to heat antibodies |
4.5% |
| axon regeneration antibodies |
4.5% |
| mature dendritic cell differentiation antibodies |
4.5% |
| flagellar cell motility antibodies |
4.5% |
| glycogen biosynthetic process antibodies |
4.5% |
| growth antibodies |
4.5% |
| phosphatidylinositol phosphorylation antibodies |
4.5% |
| secretory granule organization antibodies |
4.5% |
| trachea cartilage morphogenesis antibodies |
4.5% |
| ureteric bud morphogenesis antibodies |
4.5% |
| fourth ventricle development antibodies |
4.5% |
| glial cell development antibodies |
4.5% |
| mitochondrial membrane organization antibodies |
4.5% |
| phagocytosis, engulfment antibodies |
4.5% |
| meiotic mismatch repair antibodies |
4.5% |
| locomotory behavior antibodies |
4.5% |
| snRNA processing antibodies |
4.5% |
| transmembrane transport antibodies |
4.5% |
| renal vesicle formation antibodies |
4.5% |
| definitive hemopoiesis antibodies |
4.5% |
| neuromuscular process antibodies |
4.5% |
| cellular membrane organization antibodies |
4.5% |
| granulosa cell development antibodies |
4.5% |
| protein maturation antibodies |
4.5% |
| cell projection assembly antibodies |
4.5% |
| somatotropin secreting cell differentiation antibodies |
4.5% |
| negative chemotaxis antibodies |
4.5% |
| cochlea morphogenesis antibodies |
4.5% |
| cellular response to hydroperoxide antibodies |
4.5% |
| Schwann cell development antibodies |
4.5% |
| Schwann cell differentiation antibodies |
4.5% |
| monovalent inorganic cation transport antibodies |
4.4% |
| transcription initiation, DNA-dependent antibodies |
4.4% |
| mRNA capping antibodies |
4.4% |
| glycogen metabolic process antibodies |
4.4% |
| linoleic acid metabolic process antibodies |
4.4% |
| Golgi to plasma membrane protein transport antibodies |
4.4% |
| muscle cell development antibodies |
4.4% |
| mitochondrial translation antibodies |
4.4% |
| glyoxylate cycle antibodies |
4.4% |
| lead ion transport antibodies |
4.4% |
| guanine transport antibodies |
4.4% |
| behavior antibodies |
4.4% |
| Golgi vesicle transport antibodies |
4.4% |
| cerebral cortex development antibodies |
4.4% |
| cell motility antibodies |
4.4% |
| social behavior antibodies |
4.4% |
| epithelial cell maturation antibodies |
4.4% |
| striatum development antibodies |
4.4% |
| nuclear division antibodies |
4.4% |
| platelet activation antibodies |
4.4% |
| mRNA processing antibodies |
4.4% |
| female gamete generation antibodies |
4.4% |
| spinal cord development antibodies |
4.4% |
| gall bladder development antibodies |
4.4% |
| B cell cytokine production antibodies |
4.4% |
| vacuolar transport antibodies |
4.4% |
| eye development antibodies |
4.4% |
| cell part morphogenesis antibodies |
4.4% |
| cellular response to hypoxia antibodies |
4.4% |
| embryonic skeletal system development antibodies |
4.4% |
| outflow tract morphogenesis antibodies |
4.4% |
| response to methylmercury antibodies |
4.4% |
| plasma cell differentiation antibodies |
4.4% |
| interferon-beta production antibodies |
4.4% |
| habenula development antibodies |
4.4% |
| protein kinase C deactivation antibodies |
4.4% |
| nucleotide-excision repair, DNA incision antibodies |
4.4% |
| intestinal epithelial cell differentiation antibodies |
4.4% |
| mitochondrion organization antibodies |
4.4% |
| cellular ion homeostasis antibodies |
4.4% |
| neuropeptide signaling pathway antibodies |
4.4% |
| placenta development antibodies |
4.4% |
| T-helper 2 cell cytokine production antibodies |
4.4% |
| RNA localization antibodies |
4.4% |
| cellular aldehyde metabolic process antibodies |
4.3% |
| acetyl-CoA transport antibodies |
4.3% |
| flagellum organization antibodies |
4.3% |
| cellular response to gravity antibodies |
4.3% |
| prostate gland epithelium morphogenesis antibodies |
4.3% |
| cardiac muscle cell fate commitment antibodies |
4.3% |
| ductus arteriosus closure antibodies |
4.3% |
| fructose 6-phosphate metabolic process antibodies |
4.3% |
| protein trimerization antibodies |
4.3% |
| histone H3-K27 methylation antibodies |
4.3% |
| mesangial cell development antibodies |
4.3% |
| left lung development antibodies |
4.3% |
| Rap protein signal transduction antibodies |
4.3% |
| prostate gland development antibodies |
4.3% |
| cardiac chamber formation antibodies |
4.3% |
| cell communication antibodies |
4.3% |
| lysosome localization antibodies |
4.3% |
| vesicle docking antibodies |
4.3% |
| proximal tubule development antibodies |
4.3% |
| response to cholesterol antibodies |
4.3% |
| ear development antibodies |
4.3% |
| forebrain morphogenesis antibodies |
4.3% |
| central nervous system neuron development antibodies |
4.3% |
| cholesterol transport antibodies |
4.3% |
| type B pancreatic cell development antibodies |
4.3% |
| otic vesicle morphogenesis antibodies |
4.3% |
| steroid hormone receptor complex assembly antibodies |
4.3% |
| phosphatidylcholine metabolic process antibodies |
4.3% |
| mesonephric duct formation antibodies |
4.3% |
| cellular response to ionizing radiation antibodies |
4.3% |
| intracellular protein kinase cascade antibodies |
4.3% |
| aging antibodies |
4.3% |
| T-helper 2 cell activation antibodies |
4.3% |
| urate transport antibodies |
4.3% |
| cellular protein localization antibodies |
4.3% |
| mesenchyme migration antibodies |
4.3% |
| neural crest formation antibodies |
4.3% |
| fungiform papilla formation antibodies |
4.3% |
| telomeric loop formation antibodies |
4.3% |
| exocrine pancreas development antibodies |
4.3% |
| forebrain neuron differentiation antibodies |
4.3% |
| neutrophil extravasation antibodies |
4.3% |
| biosynthetic process antibodies |
4.3% |
| oligodendrocyte development antibodies |
4.3% |
| putamen development antibodies |
4.3% |
| nucleus localization antibodies |
4.3% |
| tendon formation antibodies |
4.3% |
| response to interleukin-6 antibodies |
4.3% |
| response to UV antibodies |
4.3% |
| oxygen homeostasis antibodies |
4.3% |
| nucleotide metabolic process antibodies |
4.3% |
| embryonic heart tube formation antibodies |
4.3% |
| hyperosmotic response antibodies |
4.3% |
| threonine transport antibodies |
4.3% |
| response to nitric oxide antibodies |
4.3% |
| glucose 6-phosphate metabolic process antibodies |
4.3% |
| seminiferous tubule development antibodies |
4.3% |
| nuclear envelope disassembly antibodies |
4.3% |
| molybdopterin cofactor biosynthetic process antibodies |
4.3% |
| translational initiation antibodies |
4.3% |
| melanocyte differentiation antibodies |
4.3% |
| cell-cell recognition antibodies |
4.2% |
| plasma membrane fusion antibodies |
4.2% |
| myoblast fusion antibodies |
4.2% |
| fibroblast activation antibodies |
4.2% |
| neural tube patterning antibodies |
4.2% |
| exocytosis antibodies |
4.2% |
| nitric oxide transport antibodies |
4.2% |
| ovarian cumulus expansion antibodies |
4.2% |
| axon extension antibodies |
4.2% |
| myotube differentiation antibodies |
4.2% |
| endothelial cell chemotaxis antibodies |
4.2% |
| cellular response to nicotine antibodies |
4.2% |
| interleukin-18 production antibodies |
4.2% |
| lung vasculature development antibodies |
4.2% |
| response to copper ion antibodies |
4.2% |
| ubiquinone biosynthetic process antibodies |
4.2% |
| sex determination antibodies |
4.2% |
| retinal cell programmed cell death antibodies |
4.2% |
| AMP phosphorylation antibodies |
4.2% |
| vitellogenesis antibodies |
4.2% |
| protein geranylgeranylation antibodies |
4.2% |
| synaptic vesicle targeting antibodies |
4.2% |
| endothelin maturation antibodies |
4.2% |
| oocyte growth antibodies |
4.2% |
| lung neuroendocrine cell differentiation antibodies |
4.2% |
| N-terminal protein amino acid acetylation antibodies |
4.2% |
| estrogen metabolic process antibodies |
4.2% |
| male germ-line stem cell division antibodies |
4.2% |
| neuron recognition antibodies |
4.2% |
| prostaglandin metabolic process antibodies |
4.2% |
| adenine metabolic process antibodies |
4.2% |
| cellular response to UV antibodies |
4.2% |
| cytochrome complex assembly antibodies |
4.2% |
| pancreas morphogenesis antibodies |
4.2% |
| cardiac myofibril assembly antibodies |
4.2% |
| bone resorption antibodies |
4.2% |
| cytokine biosynthetic process antibodies |
4.2% |
| myeloid cell differentiation antibodies |
4.2% |
| Golgi organization antibodies |
4.2% |
| metanephric mesenchyme development antibodies |
4.2% |
| telencephalon cell migration antibodies |
4.2% |
| copper ion transport antibodies |
4.2% |
| interferon-gamma-mediated signaling pathway antibodies |
4.2% |
| response to selenium ion antibodies |
4.2% |
| mitotic cell cycle G1/S transition checkpoint antibodies |
4.2% |
| protein targeting to peroxisome antibodies |
4.2% |
| definitive erythrocyte differentiation antibodies |
4.2% |
| peptidyl-amino acid modification antibodies |
4.2% |
| endodermal cell fate specification antibodies |
4.2% |
| neutral lipid metabolic process antibodies |
4.2% |
| trehalose metabolic process antibodies |
4.2% |
| vitamin B6 metabolic process antibodies |
4.2% |
| Golgi to plasma membrane transport antibodies |
4.2% |
| response to cesium ion antibodies |
4.2% |
| glycolipid metabolic process antibodies |
4.2% |
| neutrophil mediated immunity antibodies |
4.2% |
| neural tube development antibodies |
4.2% |
| spermatid development antibodies |
4.2% |
| response to lipid hydroperoxide antibodies |
4.2% |
| brain renin-angiotensin system antibodies |
4.2% |
| mammary gland fat development antibodies |
4.2% |
| forebrain cell migration antibodies |
4.2% |
| maternal behavior antibodies |
4.2% |
| eye photoreceptor cell differentiation antibodies |
4.1% |
| pyruvate biosynthetic process antibodies |
4.1% |
| B cell activation antibodies |
4.1% |
| limb development antibodies |
4.1% |
| receptor-mediated endocytosis antibodies |
4.1% |
| glycolysis antibodies |
4.1% |
| apoptotic nuclear change antibodies |
4.1% |
| endocrine pancreas development antibodies |
4.1% |
| transport antibodies |
4.1% |
| cellular response to lipid antibodies |
4.1% |
| glucagon secretion antibodies |
4.1% |
| cellular response to heat antibodies |
4.1% |
| semicircular canal development antibodies |
4.1% |
| coronary vasculature development antibodies |
4.1% |
| nucleobase transport antibodies |
4.1% |
| tricuspid valve development antibodies |
4.1% |
| ciliary cell motility antibodies |
4.1% |
| cellular response to oleic acid antibodies |
4.1% |
| L-serine transport antibodies |
4.1% |
| pentose biosynthetic process antibodies |
4.1% |
| Cdc42 protein signal transduction antibodies |
4.1% |
| carnitine biosynthetic process antibodies |
4.1% |
| retinoic acid biosynthetic process antibodies |
4.1% |
| skeletal muscle tissue development antibodies |
4.1% |
| smooth muscle hyperplasia antibodies |
4.1% |
| microtubule depolymerization antibodies |
4.1% |
| sulfur amino acid biosynthetic process antibodies |
4.1% |
| mRNA polyadenylation antibodies |
4.1% |
| skeletal system morphogenesis antibodies |
4.1% |
| hyperosmotic salinity response antibodies |
4.1% |
| carnitine shuttle antibodies |
4.1% |
| high-density lipoprotein particle remodeling antibodies |
4.1% |
| trophectodermal cell differentiation antibodies |
4.1% |
| cellular response to manganese ion antibodies |
4.1% |
| actomyosin structure organization antibodies |
4.1% |
| cytokine production involved in inflammatory response antibodies |
4.1% |
| cochlea development antibodies |
4.1% |
| cell aging antibodies |
4.1% |
| cellular response to lead ion antibodies |
4.1% |
| phosphatidylinositol dephosphorylation antibodies |
4.1% |
| signal peptide processing antibodies |
4.1% |
| muscle system process antibodies |
4.1% |
| endocardial cushion morphogenesis antibodies |
4.1% |
| pronuclear fusion antibodies |
4.1% |
| muscle filament sliding antibodies |
4.1% |
| inner ear receptor cell development antibodies |
4.1% |
| hypothalamus cell migration antibodies |
4.1% |
| cytoplasmic microtubule organization antibodies |
4.1% |
| mononuclear cell proliferation antibodies |
4.1% |
| blastocyst hatching antibodies |
4.1% |
| rhombomere 3 formation antibodies |
4.1% |
| embryonic epithelial tube formation antibodies |
4.1% |
| DNA deamination antibodies |
4.1% |
| protein glycosylation antibodies |
4.1% |
| aorta development antibodies |
4.1% |
| integrin biosynthetic process antibodies |
4.1% |
| cerebral cortex regionalization antibodies |
4.1% |
| medium-chain fatty acid transport antibodies |
4.1% |
| vasculature development antibodies |
4.1% |
| right lung morphogenesis antibodies |
4.0% |
| sodium-dependent phosphate transport antibodies |
4.0% |
| protein farnesylation antibodies |
4.0% |
| protein prenylation antibodies |
4.0% |
| nuclear envelope reassembly antibodies |
4.0% |
| protein depalmitoylation antibodies |
4.0% |
| male meiosis chromosome segregation antibodies |
4.0% |
| cellular biosynthetic process antibodies |
4.0% |
| corpus callosum morphogenesis antibodies |
4.0% |
| menarche antibodies |
4.0% |
| creatine metabolic process antibodies |
4.0% |
| cerebellum structural organization antibodies |
4.0% |
| optic vesicle morphogenesis antibodies |
4.0% |
| cardiac muscle cell development antibodies |
4.0% |
| luteinizing hormone signaling pathway antibodies |
4.0% |
| endocardium morphogenesis antibodies |
4.0% |
| response to lipid antibodies |
4.0% |
| urinary bladder development antibodies |
4.0% |
| response to activity antibodies |
4.0% |
| mitotic prophase antibodies |
4.0% |
| actin filament depolymerization antibodies |
4.0% |
| response to tumor necrosis factor antibodies |
4.0% |
| mesendoderm development antibodies |
4.0% |
| RNA-dependent DNA replication antibodies |
4.0% |
| embryonic heart tube development antibodies |
4.0% |
| cytokinesis after mitosis antibodies |
4.0% |
| dorsal spinal cord development antibodies |
4.0% |
| nucleus organization antibodies |
4.0% |
| follicular dendritic cell differentiation antibodies |
4.0% |
| mRNA transcription antibodies |
4.0% |
| organ senescence antibodies |
4.0% |
| interleukin-10 production antibodies |
4.0% |
| fertilization antibodies |
4.0% |
| response to mechanical stimulus antibodies |
4.0% |
| neuroblast fate determination antibodies |
4.0% |
| cGMP-mediated signaling antibodies |
4.0% |
| retrograde protein transport, ER to cytosol antibodies |
4.0% |
| response to acidity antibodies |
4.0% |
| sphingomyelin metabolic process antibodies |
4.0% |
| spermatogenesis antibodies |
4.0% |
| oogenesis antibodies |
4.0% |
| cellular component movement antibodies |
4.0% |
| sperm motility antibodies |
4.0% |
| endothelium development antibodies |
4.0% |
| respiratory electron transport chain antibodies |
4.0% |
| proprioception antibodies |
4.0% |
| cellular response to lipopolysaccharide antibodies |
4.0% |
| locomotor rhythm antibodies |
4.0% |
| cartilage condensation antibodies |
4.0% |
| mechanoreceptor differentiation antibodies |
4.0% |
| T cell chemotaxis antibodies |
4.0% |
| protein deamination antibodies |
4.0% |
| parturition antibodies |
4.0% |
| T cell selection antibodies |
4.0% |
| neutrophil activation antibodies |
4.0% |
| cell division antibodies |
4.0% |
| antimicrobial humoral response antibodies |
4.0% |
| chromosome organization antibodies |
4.0% |
| cellular response to fatty acid antibodies |
4.0% |
| central nervous system myelin formation antibodies |
4.0% |
| endocytosis antibodies |
4.0% |
| T cell differentiation antibodies |
4.0% |
| cellular pigment accumulation antibodies |
4.0% |
| otolith development antibodies |
4.0% |
| T cell mediated immunity antibodies |
4.0% |
| T cell activation antibodies |
4.0% |
| myeloid progenitor cell differentiation antibodies |
4.0% |
| endoplasmic reticulum membrane fusion antibodies |
4.0% |
| midbrain-hindbrain boundary development antibodies |
4.0% |
| membrane lipid metabolic process antibodies |
4.0% |
| cellular response to cholesterol antibodies |
3.9% |
| transmembrane receptor protein tyrosine phosphatase signaling pathway antibodies |
3.9% |
| RNA polyadenylation antibodies |
3.9% |
| response to radiation antibodies |
3.9% |
| smooth muscle hypertrophy antibodies |
3.9% |
| contact inhibition antibodies |
3.9% |
| metanephric mesenchymal cell differentiation antibodies |
3.9% |
| glycine metabolic process antibodies |
3.9% |
| glomerular basement membrane development antibodies |
3.9% |
| cellular response to copper ion antibodies |
3.9% |
| Golgi localization antibodies |
3.9% |
| selenocysteine incorporation antibodies |
3.9% |
| receptor biosynthetic process antibodies |
3.9% |
| blood vessel development antibodies |
3.9% |
| protein poly-ADP-ribosylation antibodies |
3.9% |
| nose development antibodies |
3.9% |
| epidermis morphogenesis antibodies |
3.9% |
| epidermal cell differentiation antibodies |
3.9% |
| thrombin receptor signaling pathway antibodies |
3.9% |
| B-1 B cell homeostasis antibodies |
3.9% |
| cellular response to interferon-beta antibodies |
3.9% |
| sensory epithelium regeneration antibodies |
3.9% |
| succinyl-CoA pathway antibodies |
3.9% |
| retinal rod cell differentiation antibodies |
3.9% |
| positive chemotaxis antibodies |
3.9% |
| DNA mediated transformation antibodies |
3.9% |
| monocyte differentiation antibodies |
3.9% |
| monocyte extravasation antibodies |
3.9% |
| malate-aspartate shuttle antibodies |
3.9% |
| Rac protein signal transduction antibodies |
3.9% |
| response to nicotine antibodies |
3.9% |
| optokinetic behavior antibodies |
3.9% |
| carbohydrate metabolic process antibodies |
3.9% |
| protein O-linked glycosylation antibodies |
3.9% |
| blood coagulation, intrinsic pathway antibodies |
3.9% |
| inner medullary collecting duct development antibodies |
3.9% |
| meiosis antibodies |
3.9% |
| placenta blood vessel development antibodies |
3.9% |
| reciprocal meiotic recombination antibodies |
3.9% |
| visual learning antibodies |
3.9% |
| metanephric nephron morphogenesis antibodies |
3.9% |
| viral transcription antibodies |
3.9% |
| pro-B cell differentiation antibodies |
3.9% |
| B cell affinity maturation antibodies |
3.9% |
| RNA splicing antibodies |
3.9% |
| DNA cytosine deamination antibodies |
3.9% |
| protein autoprocessing antibodies |
3.9% |
| olfactory placode formation antibodies |
3.9% |
| brain morphogenesis antibodies |
3.9% |
| cell volume homeostasis antibodies |
3.9% |
| ureteric bud formation antibodies |
3.9% |
| oocyte differentiation antibodies |
3.9% |
| blastocyst development antibodies |
3.9% |
| embryonic skeletal system morphogenesis antibodies |
3.9% |
| mitochondrial transport antibodies |
3.9% |
| CD40 signaling pathway antibodies |
3.9% |
| cardiac vascular smooth muscle cell development antibodies |
3.9% |
| synaptic vesicle transport antibodies |
3.9% |
| atrial septum development antibodies |
3.9% |
| Ras protein signal transduction antibodies |
3.9% |
| cellular response to calcium ion antibodies |
3.9% |
| sex differentiation antibodies |
3.9% |
| proton transport antibodies |
3.9% |
| protein transport antibodies |
3.8% |
| fungiform papilla morphogenesis antibodies |
3.8% |
| mesodermal cell fate commitment antibodies |
3.8% |
| atrioventricular node cell development antibodies |
3.8% |
| response to iron(II) ion antibodies |
3.8% |
| seryl-tRNA aminoacylation antibodies |
3.8% |
| thyroid hormone metabolic process antibodies |
3.8% |
| thiamine transmembrane transport antibodies |
3.8% |
| GMP salvage antibodies |
3.8% |
| cytokine production involved in immune response antibodies |
3.8% |
| response to pheromone antibodies |
3.8% |
| rhombomere 5 formation antibodies |
3.8% |
| manganese ion transport antibodies |
3.8% |
| L-serine biosynthetic process antibodies |
3.8% |
| common bile duct development antibodies |
3.8% |
| organelle organization antibodies |
3.8% |
| cerebral cortex neuron differentiation antibodies |
3.8% |
| brainstem development antibodies |
3.8% |
| nerve development antibodies |
3.8% |
| metanephric nephron development antibodies |
3.8% |
| mammary gland epithelium development antibodies |
3.8% |
| growth plate cartilage development antibodies |
3.8% |
| endocardium development antibodies |
3.8% |
| leucine import antibodies |
3.8% |
| response to virus antibodies |
3.8% |
| mature ribosome assembly antibodies |
3.8% |
| isoprenoid metabolic process antibodies |
3.8% |
| pigment granule transport antibodies |
3.8% |
| radial pattern formation antibodies |
3.8% |
| macrophage differentiation antibodies |
3.8% |
| endochondral bone growth antibodies |
3.8% |
| sensory perception antibodies |
3.8% |
| mast cell mediated immunity antibodies |
3.8% |
| auditory behavior antibodies |
3.8% |
| ventricular system development antibodies |
3.8% |
| synapse organization antibodies |
3.8% |
| auditory receptor cell development antibodies |
3.8% |
| inferior colliculus development antibodies |
3.8% |
| neuron projection development antibodies |
3.8% |
| protein localization in membrane antibodies |
3.8% |
| somatic cell DNA recombination antibodies |
3.8% |
| peptide antigen transport antibodies |
3.8% |
| multicellular organism growth antibodies |
3.8% |
| lipoprotein transport antibodies |
3.8% |
| response to bacterium antibodies |
3.8% |
| calcium ion transmembrane transport antibodies |
3.8% |
| mitochondrial citrate transport antibodies |
3.8% |
| formaldehyde biosynthetic process antibodies |
3.8% |
| B cell mediated immunity antibodies |
3.8% |
| foregut morphogenesis antibodies |
3.8% |
| natural killer cell differentiation antibodies |
3.8% |
| mesenchyme development antibodies |
3.8% |
| mitotic cell cycle G2/M transition checkpoint antibodies |
3.8% |
| adult locomotory behavior antibodies |
3.8% |
| very-low-density lipoprotein particle clearance antibodies |
3.8% |
| ribonucleoside monophosphate biosynthetic process antibodies |
3.8% |
| transcription termination, DNA-dependent antibodies |
3.8% |
| G-protein coupled purinergic nucleotide receptor signaling pathway antibodies |
3.8% |
| cerebellar granule cell differentiation antibodies |
3.8% |
| myofibril assembly antibodies |
3.8% |
| response to ionizing radiation antibodies |
3.8% |
| decidualization antibodies |
3.8% |
| cilium movement antibodies |
3.8% |
| lens fiber cell development antibodies |
3.8% |
| glomerular mesangial cell development antibodies |
3.8% |
| intracellular protein transport antibodies |
3.8% |
| muscle fiber development antibodies |
3.8% |
| interleukin-12 secretion antibodies |
3.8% |
| thyroid hormone generation antibodies |
3.8% |
| potassium ion export antibodies |
3.8% |
| parathyroid gland development antibodies |
3.7% |
| sperm capacitation antibodies |
3.7% |
| thalamus development antibodies |
3.7% |
| cellular calcium ion homeostasis antibodies |
3.7% |
| interleukin-12 production antibodies |
3.7% |
| peptide biosynthetic process antibodies |
3.7% |
| ketone body biosynthetic process antibodies |
3.7% |
| nucleoside diphosphate biosynthetic process antibodies |
3.7% |
| interleukin-6 biosynthetic process antibodies |
3.7% |
| cardiac septum development antibodies |
3.7% |
| gamma-aminobutyric acid signaling pathway antibodies |
3.7% |
| Harderian gland development antibodies |
3.7% |
| B cell negative selection antibodies |
3.7% |
| tricuspid valve formation antibodies |
3.7% |
| mesoderm formation antibodies |
3.7% |
| membrane protein proteolysis antibodies |
3.7% |
| fatty acid transport antibodies |
3.7% |
| peripheral nervous system neuron development antibodies |
3.7% |
| cellular response to metal ion antibodies |
3.7% |
| renal glucose absorption antibodies |
3.7% |
| granulosa cell differentiation antibodies |
3.7% |
| collagen biosynthetic process antibodies |
3.7% |
| organ induction antibodies |
3.7% |
| tube morphogenesis antibodies |
3.7% |
| steroid catabolic process antibodies |
3.7% |
| sodium ion export antibodies |
3.7% |
| response to hormone stimulus antibodies |
3.7% |
| primitive streak formation antibodies |
3.7% |
| intracellular copper ion transport antibodies |
3.7% |
| natural killer cell chemotaxis antibodies |
3.7% |
| osteoblast fate commitment antibodies |
3.7% |
| cadmium ion transmembrane transport antibodies |
3.7% |
| CDP-diacylglycerol biosynthetic process antibodies |
3.7% |
| enteric smooth muscle cell differentiation antibodies |
3.7% |
| photoreactive repair antibodies |
3.7% |
| thymine transport antibodies |
3.7% |
| cellular response to morphine antibodies |
3.7% |
| mitochondrial electron transport, succinate to ubiquinone antibodies |
3.7% |
| renal inner medulla development antibodies |
3.7% |
| thiamine diphosphate biosynthetic process antibodies |
3.7% |
| tRNA 3-trailer cleavage antibodies |
3.7% |
| DNA strand elongation antibodies |
3.7% |
| carnitine transport antibodies |
3.7% |
| heme transport antibodies |
3.7% |
| urea metabolic process antibodies |
3.7% |
| tetrapyrrole biosynthetic process antibodies |
3.7% |
| embryonic hindgut morphogenesis antibodies |
3.7% |
| nerve growth factor processing antibodies |
3.7% |
| cellular response to tumor necrosis factor antibodies |
3.7% |
| hormone catabolic process antibodies |
3.7% |
| response to metal ion antibodies |
3.7% |
| nuclear mRNA 5-splice site recognition antibodies |
3.7% |
| peroxisomal membrane transport antibodies |
3.7% |
| ventricular cardiac muscle cell development antibodies |
3.7% |
| cervix development antibodies |
3.7% |
| organic anion transport antibodies |
3.7% |
| anatomical structure morphogenesis antibodies |
3.7% |
| rhombomere 2 development antibodies |
3.7% |
| carbohydrate phosphorylation antibodies |
3.7% |
| glutamine biosynthetic process antibodies |
3.7% |
| response to sulfur dioxide antibodies |
3.7% |
| protein N-linked glycosylation antibodies |
3.7% |
| eye photoreceptor cell development antibodies |
3.7% |
| response to zinc ion antibodies |
3.7% |
| FAD biosynthetic process antibodies |
3.7% |
| fatty-acyl-CoA biosynthetic process antibodies |
3.7% |
| translation antibodies |
3.7% |
| cation transport antibodies |
3.6% |
| notochord development antibodies |
3.6% |
| insulin secretion antibodies |
3.6% |
| skeletal muscle tissue growth antibodies |
3.6% |
| response to amino acid stimulus antibodies |
3.6% |
| mitral valve morphogenesis antibodies |
3.6% |
| mannose metabolic process antibodies |
3.6% |
| telomeric 3 overhang formation antibodies |
3.6% |
| adult behavior antibodies |
3.6% |
| adult feeding behavior antibodies |
3.6% |
| positive T cell selection antibodies |
3.6% |
| embryonic heart tube morphogenesis antibodies |
3.6% |
| skeletal muscle fiber development antibodies |
3.6% |
| lymphocyte proliferation antibodies |
3.6% |
| urea cycle antibodies |
3.6% |
| gluconeogenesis antibodies |
3.6% |
| tissue morphogenesis antibodies |
3.6% |
| polysaccharide catabolic process antibodies |
3.6% |
| calcium-dependent cell-matrix adhesion antibodies |
3.6% |
| optic placode formation antibodies |
3.6% |
| neural plate development antibodies |
3.6% |
| nerve maturation antibodies |
3.6% |
| pigmentation antibodies |
3.6% |
| molecular hydrogen transport antibodies |
3.6% |
| spleen development antibodies |
3.6% |
| siderophore transport antibodies |
3.6% |
| cellular response to potassium ion antibodies |
3.6% |
| ectodermal placode formation antibodies |
3.6% |
| hypochlorous acid biosynthetic process antibodies |
3.6% |
| melanin biosynthetic process antibodies |
3.6% |
| lipid glycosylation antibodies |
3.6% |
| megakaryocyte development antibodies |
3.6% |
| intracellular cholesterol transport antibodies |
3.6% |
| righting reflex antibodies |
3.6% |
| embryonic skeletal joint development antibodies |
3.6% |
| neural fold formation antibodies |
3.6% |
| phagocytosis antibodies |
3.6% |
| sterol metabolic process antibodies |
3.6% |
| ceramide biosynthetic process antibodies |
3.6% |
| salivary gland morphogenesis antibodies |
3.6% |
| response to muscle activity antibodies |
3.6% |
| feeding behavior antibodies |
3.6% |
| glutathione transport antibodies |
3.6% |
| embryonic pattern specification antibodies |
3.6% |
| response to lipopolysaccharide antibodies |
3.6% |
| vagina development antibodies |
3.6% |
| blastocyst formation antibodies |
3.6% |
| epithelium development antibodies |
3.6% |
| response to glucose stimulus antibodies |
3.6% |
| astral microtubule organization antibodies |
3.6% |
| cellular response to gonadotropin-releasing hormone antibodies |
3.6% |
| Bergmann glial cell differentiation antibodies |
3.6% |
| cobalamin metabolic process antibodies |
3.6% |
| cellular response to caffeine antibodies |
3.6% |
| protein localization to chromatin antibodies |
3.6% |
| platelet activating factor metabolic process antibodies |
3.6% |
| extrathymic T cell selection antibodies |
3.6% |
| ion transmembrane transport antibodies |
3.6% |
| adult heart development antibodies |
3.6% |
| cytosolic calcium ion homeostasis antibodies |
3.6% |
| B cell chemotaxis antibodies |
3.6% |
| triglyceride transport antibodies |
3.6% |
| terpene metabolic process antibodies |
3.6% |
| depurination antibodies |
3.6% |
| interferon-gamma production antibodies |
3.6% |
| mitotic chromosome condensation antibodies |
3.6% |
| adenosine metabolic process antibodies |
3.6% |
| nucleotide-excision repair, DNA damage removal antibodies |
3.5% |
| mesodermal cell migration antibodies |
3.5% |
| pharyngeal system development antibodies |
3.5% |
| limbic system development antibodies |
3.5% |
| plasminogen activation antibodies |
3.5% |
| mesoderm development antibodies |
3.5% |
| T cell costimulation antibodies |
3.5% |
| nipple morphogenesis antibodies |
3.5% |
| response to acid antibodies |
3.5% |
| NK T cell differentiation antibodies |
3.5% |
| skeletal muscle organ development antibodies |
3.5% |
| cellular response to pH antibodies |
3.5% |
| metanephric ureteric bud development antibodies |
3.5% |
| chemotaxis antibodies |
3.5% |
| rhombomere development antibodies |
3.5% |
| tail morphogenesis antibodies |
3.5% |
| fructose biosynthetic process antibodies |
3.5% |
| neural plate morphogenesis antibodies |
3.5% |
| cellular pigmentation antibodies |
3.5% |
| glycolipid biosynthetic process antibodies |
3.5% |
| interleukin-1 secretion antibodies |
3.5% |
| nitric oxide biosynthetic process antibodies |
3.5% |
| cellular heat acclimation antibodies |
3.5% |
| ventral midline determination antibodies |
3.5% |
| phosphate ion homeostasis antibodies |
3.5% |
| lymphocyte migration antibodies |
3.5% |
| female sex determination antibodies |
3.5% |
| cardiac ventricle development antibodies |
3.5% |
| response to protozoan antibodies |
3.5% |
| arginine metabolic process antibodies |
3.5% |
| endomitotic cell cycle antibodies |
3.5% |
| forebrain ventricular zone progenitor cell division antibodies |
3.5% |
| nuclear mRNA splicing, via spliceosome antibodies |
3.5% |
| organ morphogenesis antibodies |
3.5% |
| ATP transport antibodies |
3.5% |
| third ventricle development antibodies |
3.5% |
| neural tube formation antibodies |
3.5% |
| response to calcium ion antibodies |
3.5% |
| glutamate biosynthetic process antibodies |
3.5% |
| cobalamin transport antibodies |
3.5% |
| response to carbon monoxide antibodies |
3.5% |
| centriole replication antibodies |
3.5% |
| phosphatidylinositol biosynthetic process antibodies |
3.5% |
| somite development antibodies |
3.5% |
| glycerol biosynthetic process antibodies |
3.5% |
| membranous septum morphogenesis antibodies |
3.5% |
| anterior commissure morphogenesis antibodies |
3.5% |
| pallium development antibodies |
3.5% |
| embryo implantation antibodies |
3.5% |
| ventral cord development antibodies |
3.5% |
| oogenesis stage antibodies |
3.5% |
| interleukin-8 biosynthetic process antibodies |
3.5% |
| translational elongation antibodies |
3.5% |
| inhibitory G-protein coupled receptor phosphorylation antibodies |
3.5% |
| B cell differentiation antibodies |
3.5% |
| cellular membrane fusion antibodies |
3.5% |
| base-excision repair, AP site formation antibodies |
3.5% |
| inner ear morphogenesis antibodies |
3.5% |
| asparagine biosynthetic process antibodies |
3.5% |
| iodide transport antibodies |
3.5% |
| kidney morphogenesis antibodies |
3.5% |
| viral genome replication antibodies |
3.5% |
| intracellular transport antibodies |
3.5% |
| DNA duplex unwinding antibodies |
3.5% |
| conditioned taste aversion antibodies |
3.5% |
| cellular response to tumor cell antibodies |
3.5% |
| response to peptide hormone stimulus antibodies |
3.4% |
| metanephric nephron tubule development antibodies |
3.4% |
| GPI anchor biosynthetic process antibodies |
3.4% |
| adenosine catabolic process antibodies |
3.4% |
| naphthalene metabolic process antibodies |
3.4% |
| estrogen biosynthetic process antibodies |
3.4% |
| macrophage fusion antibodies |
3.4% |
| ovarian follicle development antibodies |
3.4% |
| cytidine deamination antibodies |
3.4% |
| transferrin transport antibodies |
3.4% |
| lipid biosynthetic process antibodies |
3.4% |
| inositol phosphorylation antibodies |
3.4% |
| axon target recognition antibodies |
3.4% |
| heme oxidation antibodies |
3.4% |
| lung epithelium development antibodies |
3.4% |
| negative T cell selection antibodies |
3.4% |
| oligosaccharide biosynthetic process antibodies |
3.4% |
| lipid oxidation antibodies |
3.4% |
| cellular response to chromate antibodies |
3.4% |
| rhodopsin mediated phototransduction antibodies |
3.4% |
| notochord cell development antibodies |
3.4% |
| cerebellum development antibodies |
3.4% |
| response to interferon-beta antibodies |
3.4% |
| palate development antibodies |
3.4% |
| cytoplasm organization antibodies |
3.4% |
| eye morphogenesis antibodies |
3.4% |
| cellular response to acid antibodies |
3.4% |
| L-ascorbic acid transport antibodies |
3.4% |
| response to morphine antibodies |
3.4% |
| menopause antibodies |
3.4% |
| ureter development antibodies |
3.4% |
| aspartate biosynthetic process antibodies |
3.4% |
| cobalt ion transport antibodies |
3.4% |
| urate biosynthetic process antibodies |
3.4% |
| pulmonary valve morphogenesis antibodies |
3.4% |
| response to pH antibodies |
3.4% |
| cellular response to ethanol antibodies |
3.4% |
| semicircular canal morphogenesis antibodies |
3.4% |
| quinolinate biosynthetic process antibodies |
3.4% |
| pronephric duct morphogenesis antibodies |
3.4% |
| renal outer medulla development antibodies |
3.4% |
| heart valve formation antibodies |
3.4% |
| spinal cord motor neuron differentiation antibodies |
3.4% |
| monosaccharide metabolic process antibodies |
3.4% |
| male sex determination antibodies |
3.4% |
| pulmonary valve formation antibodies |
3.4% |
| behavioral response to nicotine antibodies |
3.4% |
| lipoxygenase pathway antibodies |
3.4% |
| inner cell mass cellular morphogenesis antibodies |
3.4% |
| meiotic gene conversion antibodies |
3.4% |
| epithelial fluid transport antibodies |
3.4% |
| heme biosynthetic process antibodies |
3.4% |
| cellular respiration antibodies |
3.4% |
| glycoprotein biosynthetic process antibodies |
3.4% |
| barbed-end actin filament capping antibodies |
3.4% |
| trehalose biosynthetic process antibodies |
3.4% |
| long-chain fatty acid transport antibodies |
3.4% |
| nerve growth factor production antibodies |
3.4% |
| vitamin D biosynthetic process antibodies |
3.4% |
| arginine transport antibodies |
3.4% |
| protein sulfation antibodies |
3.4% |
| CD4-positive, alpha-beta T cell proliferation antibodies |
3.4% |
| cloaca development antibodies |
3.4% |
| uterine epithelium development antibodies |
3.3% |
| muscle hypertrophy antibodies |
3.3% |
| cholesterol biosynthetic process antibodies |
3.3% |
| serotonin transport antibodies |
3.3% |
| amino acid transmembrane transport antibodies |
3.3% |
| polyamine homeostasis antibodies |
3.3% |
| digestive system development antibodies |
3.3% |
| embryonic hemopoiesis antibodies |
3.3% |
| cytoplasmic transport antibodies |
3.3% |
| oxygen transport antibodies |
3.3% |
| acrosome reaction antibodies |
3.3% |
| neuron cell-cell adhesion antibodies |
3.3% |
| facial nerve structural organization antibodies |
3.3% |
| cellular response to cell-matrix adhesion antibodies |
3.3% |
| mesonephric duct development antibodies |
3.3% |
| sphingolipid metabolic process antibodies |
3.3% |
| glucocorticoid metabolic process antibodies |
3.3% |
| response to UV-A antibodies |
3.3% |
| cocaine metabolic process antibodies |
3.3% |
| N-terminal protein amino acid modification antibodies |
3.3% |
| forebrain regionalization antibodies |
3.3% |
| cell chemotaxis antibodies |
3.3% |
| translational frameshifting antibodies |
3.3% |
| cristae formation antibodies |
3.3% |
| response to cocaine antibodies |
3.3% |
| cellular glucuronidation antibodies |
3.3% |
| protein deglycosylation antibodies |
3.3% |
| extracellular polysaccharide biosynthetic process antibodies |
3.3% |
| proboscis development antibodies |
3.3% |
| lung lobe formation antibodies |
3.3% |
| DNA replication proofreading antibodies |
3.3% |
| glutathione biosynthetic process antibodies |
3.3% |
| circadian behavior antibodies |
3.3% |
| lateral mesoderm formation antibodies |
3.3% |
| tryptophan transport antibodies |
3.3% |
| vocalization behavior antibodies |
3.3% |
| diplotene antibodies |
3.3% |
| digestion antibodies |
3.3% |
| grooming behavior antibodies |
3.3% |
| phospholipid translocation antibodies |
3.3% |
| tRNA methylation antibodies |
3.3% |
| lipopolysaccharide biosynthetic process antibodies |
3.3% |
| peptide transport antibodies |
3.3% |
| hexose metabolic process antibodies |
3.3% |
| bile acid biosynthetic process antibodies |
3.3% |
| neural fold elevation formation antibodies |
3.3% |
| oligosaccharide metabolic process antibodies |
3.3% |
| sperm axoneme assembly antibodies |
3.3% |
| glutamyl-tRNA aminoacylation antibodies |
3.3% |
| neuromuscular junction development antibodies |
3.3% |
| response to tumor cell antibodies |
3.3% |
| vitamin K biosynthetic process antibodies |
3.3% |
| leucine biosynthetic process antibodies |
3.3% |
| response to manganese ion antibodies |
3.3% |
| rhombomere 5 development antibodies |
3.3% |
| immunoglobulin V(D)J recombination antibodies |
3.3% |
| nephron tubule development antibodies |
3.3% |
| GTP biosynthetic process antibodies |
3.3% |
| embryonic organ development antibodies |
3.3% |
| visual perception antibodies |
3.3% |
| iron ion transport antibodies |
3.3% |
| floor plate development antibodies |
3.3% |
| protein-pyridoxal-5-phosphate linkage antibodies |
3.3% |
| carbohydrate biosynthetic process antibodies |
3.3% |
| mitochondrion morphogenesis antibodies |
3.3% |
| Golgi vesicle budding antibodies |
3.3% |
| clathrin coat assembly antibodies |
3.3% |
| intracellular virion transport antibodies |
3.2% |
| mast cell differentiation antibodies |
3.2% |
| keratinization antibodies |
3.2% |
| calcium-dependent cell-cell adhesion antibodies |
3.2% |
| toxin biosynthetic process antibodies |
3.2% |
| forebrain astrocyte development antibodies |
3.2% |
| drinking behavior antibodies |
3.2% |
| blood vessel morphogenesis antibodies |
3.2% |
| mitotic metaphase antibodies |
3.2% |
| ornithine metabolic process antibodies |
3.2% |
| postsynaptic density protein 95 clustering antibodies |
3.2% |
| spinal cord motor neuron cell fate specification antibodies |
3.2% |
| antibiotic metabolic process antibodies |
3.2% |
| ventral spinal cord development antibodies |
3.2% |
| dicarboxylic acid metabolic process antibodies |
3.2% |
| glucocorticoid catabolic process antibodies |
3.2% |
| guanine salvage antibodies |
3.2% |
| tyrosine transport antibodies |
3.2% |
| ventricular septum development antibodies |
3.2% |
| endochondral bone morphogenesis antibodies |
3.2% |
| lipid transport antibodies |
3.2% |
| sphingolipid biosynthetic process antibodies |
3.2% |
| cellular response to drug antibodies |
3.2% |
| optic nerve morphogenesis antibodies |
3.2% |
| optic nerve development antibodies |
3.2% |
| dendrite regeneration antibodies |
3.2% |
| lateral mesoderm development antibodies |
3.2% |
| response to ethanol antibodies |
3.2% |
| cellular response to antibiotic antibodies |
3.2% |
| hyaluronan biosynthetic process antibodies |
3.2% |
| calcium ion homeostasis antibodies |
3.2% |
| thymic T cell selection antibodies |
3.2% |
| lung connective tissue development antibodies |
3.2% |
| cellular metal ion homeostasis antibodies |
3.2% |
| lens fiber cell differentiation antibodies |
3.2% |
| complement activation antibodies |
3.2% |
| cellular ketone metabolic process antibodies |
3.2% |
| inorganic diphosphate transport antibodies |
3.2% |
| glomerular mesangial cell proliferation antibodies |
3.2% |
| leukocyte migration antibodies |
3.2% |
| glomerular endothelium development antibodies |
3.2% |
| gland development antibodies |
3.2% |
| hair cycle process antibodies |
3.2% |
| response to cGMP antibodies |
3.2% |
| cardiolipin biosynthetic process antibodies |
3.2% |
| histone H3-K9 methylation antibodies |
3.2% |
| mitochondrial RNA 3-end processing antibodies |
3.2% |
| thymus development antibodies |
3.2% |
| response to toxin antibodies |
3.2% |
| glycerol transport antibodies |
3.2% |
| ectoderm formation antibodies |
3.2% |
| exocrine system development antibodies |
3.2% |
| pyrimidine nucleoside salvage antibodies |
3.2% |
| response to cadmium ion antibodies |
3.2% |
| aspartate transport antibodies |
3.2% |
| embryonic cleavage antibodies |
3.2% |
| FasL biosynthetic process antibodies |
3.2% |
| DNA replication antibodies |
3.2% |
| erythrocyte development antibodies |
3.2% |
| cellular polysaccharide biosynthetic process antibodies |
3.2% |
| cardiac muscle tissue morphogenesis antibodies |
3.2% |
| oxalic acid secretion antibodies |
3.2% |
| central nervous system morphogenesis antibodies |
3.2% |
| nose morphogenesis antibodies |
3.2% |
| iris morphogenesis antibodies |
3.2% |
| opsonization antibodies |
3.2% |
| ATP synthesis coupled electron transport antibodies |
3.1% |
| muscle organ development antibodies |
3.1% |
| histidine biosynthetic process antibodies |
3.1% |
| ureter morphogenesis antibodies |
3.1% |
| caudate nucleus development antibodies |
3.1% |
| phosphatidylethanolamine biosynthetic process antibodies |
3.1% |
| phospholipid metabolic process antibodies |
3.1% |
| external genitalia morphogenesis antibodies |
3.1% |
| B cell costimulation antibodies |
3.1% |
| desmosome disassembly antibodies |
3.1% |
| respiratory burst after phagocytosis antibodies |
3.1% |
| formaldehyde metabolic process antibodies |
3.1% |
| glandular epithelial cell maturation antibodies |
3.1% |
| hypoxanthine metabolic process antibodies |
3.1% |
| response to vitamin B6 antibodies |
3.1% |
| bone morphogenesis antibodies |
3.1% |
| thyroid hormone transport antibodies |
3.1% |
| phototransduction antibodies |
3.1% |
| hypotonic response antibodies |
3.1% |
| lymphocyte chemotaxis antibodies |
3.1% |
| rRNA transcription antibodies |
3.1% |
| striated muscle cell development antibodies |
3.1% |
| ear morphogenesis antibodies |
3.1% |
| cysteine biosynthetic process antibodies |
3.1% |
| cerebellar cortex development antibodies |
3.1% |
| response to iron ion antibodies |
3.1% |
| ion homeostasis antibodies |
3.1% |
| negative thymic T cell selection antibodies |
3.1% |
| organelle fusion antibodies |
3.1% |
| forebrain neuron development antibodies |
3.1% |
| response to insecticide antibodies |
3.1% |
| response to antibiotic antibodies |
3.1% |
| transcription, DNA-dependent antibodies |
3.1% |
| intestinal cholesterol absorption antibodies |
3.1% |
| platelet aggregation antibodies |
3.1% |
| leukocyte degranulation antibodies |
3.1% |
| cellular response to interleukin-1 antibodies |
3.1% |
| pseudouridine synthesis antibodies |
3.1% |
| notochord formation antibodies |
3.1% |
| heart jogging antibodies |
3.1% |
| neural plate pattern specification antibodies |
3.1% |
| response to dietary excess antibodies |
3.1% |
| forelimb morphogenesis antibodies |
3.1% |
| neuron projection morphogenesis antibodies |
3.1% |
| uterus development antibodies |
3.1% |
| retina layer formation antibodies |
3.1% |
| cardiac muscle tissue development antibodies |
3.1% |
| UV-damage excision repair antibodies |
3.1% |
| ectoderm development antibodies |
3.1% |
| hemoglobin biosynthetic process antibodies |
3.1% |
| cellular response to hyperoxia antibodies |
3.1% |
| cerebellar Purkinje cell differentiation antibodies |
3.0% |
| telencephalon development antibodies |
3.0% |
| biological_process antibodies |
3.0% |
| glycoprotein transport antibodies |
3.0% |
| cellular response to interferon-gamma antibodies |
3.0% |
| lactation antibodies |
3.0% |
| response to ozone antibodies |
3.0% |
| dopamine transport antibodies |
3.0% |
| cardiac conduction system development antibodies |
3.0% |
| homophilic cell adhesion antibodies |
3.0% |
| mitochondrion distribution antibodies |
3.0% |
| internal protein amino acid acetylation antibodies |
3.0% |
| choline metabolic process antibodies |
3.0% |
| minus-end-directed organelle transport along microtubule antibodies |
3.0% |
| interleukin-2 biosynthetic process antibodies |
3.0% |
| phosphatidylserine biosynthetic process antibodies |
3.0% |
| L-cystine transport antibodies |
3.0% |
| tear secretion antibodies |
3.0% |
| synaptic transmission, dopaminergic antibodies |
3.0% |
| embryonic digestive tract morphogenesis antibodies |
3.0% |
| fructose transport antibodies |
3.0% |
| cellular senescence antibodies |
3.0% |
| macrophage chemotaxis antibodies |
3.0% |
| phospholipid efflux antibodies |
3.0% |
| syncytium formation antibodies |
3.0% |
Pingback: HOXC6 Antibody (ARP38484_P050) – Associated Pathways | Aviva Systems Biology Reagents and Antibodies